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ABSTRACT
Previous research has shown exercise to be beneficial in the treatment of
myositis-affected patients. However, the potential of functional exercises to improve
muscle strength and function in the absence of disease progression markers in
patient's with Inclusion Body Myositis (IBM) is not well understood. It is believed
that the initial exercise dose and patient specificity is of paramount importance in the
successful use of this modality in the routine :inanagement and long term treatment of
such patients. The objective of this study was to investigate the effects of a homebased, patient-specific functional exercise programme, including aerobic exercise and
resistance training, on muscle strength, endurance and function, and the aerobic
capacity of the patient.

Pre muscle strength and functional assessments, and a maximal aerobic
exercise test were conducted on seven IBM patients' prior to a 12-week training
period. As part of the patient's routine management, the patients maintained their
scheduled visits to the neuromuscular clinic whereby their serum creatine kinase (CK)
levels were assessed pre- and post-training intervention. The patients' were gently
and selectively overloaded in the early stages of their 12-week exercise program to
encourage compliance and gradual adaptation, and to prevent 'overtraining' early in
the program.

The exercise program combined upper and lower body resistance

training exercises with an aerobic component.

It was anticipated that the patients would exercise frequently at low intensities

and at volumes that would optimally induce muscular strength and endurance
improvements. Integral to the prescription of exercise for this patient group was the
patient-specificity of the exercise dose being prescribed and the method of exercise
overload.

The patient's progress was monitored by fortnightly phone calls;

maintenance of the patients scheduled visits to their specialist at the neuromuscular
clinic, and a 'training diary' was given to the patient to fill out daily.

At the

conclusion of the training intervention period, all parameters of muscle strength and
function were reassessed, and the patients undertook follow-up testing of their
maximal aerobic capacity.
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The results show that, a diseased muscle, having undergone exercise training,
maintained its strength (knee extension [100.9±10%]) (mean±standard error [SE]),
whilst significant improvements (p < 0.05) were observed in otherwise healthy,
trained muscles, with hip abduction strength improving by 59.1±31 %, shoulder
abduction strength increasing by 66.1±12% and hip flexion strength increasing by
83.7±35%.

Functional assessments showed that there was not a statistically

significant improvement in the time taken to perform a stair climb and walk 30
metres, and also the amount of paces used during the walk. However, the patient
group improved in all functional tasks.

Research suggests that muscle strength and function can be improved by
resistance training and an aerobic exercise program. However, further research is
required to evaluate the effects of a mild, daily, exercise program performed in the
patient's home.

Exercise guidelines for this clinical population are substantially

lacking. However, this study has added to the current depth of knowledge regarding
exercise and Inclusion Body Myositis patients'. Program adherence, exercise
prescription and progression and program monitoring are areas which require further
examination in long-term, multi-centre exercise intervention trials. It would appear
that an exercise program tailored to the individual is important for the clinical
management ofthe disease.
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1. Introduction

Inclusion Body Myositis (IBM) is an idiopathic inflammatory myopathy (liM)
that is characterized by progressive muscle weakness and reduced muscle strength,
endurance and function (Alexanderson & Lundberg, 2005; Mastaglia, Garlepp &
Phillips, 2003). It is the most common inflammatory myopathy amongst adults over
50 years of age and is more common in men than women (Felice, Relva & Conway,
1998; Ranque-Francois, Maisonobe, Dion, Piette, Chauveheid, Amoura & Papo,
2005; Sivakumar & Dalakas, 1997; Vogel, 1998). Prominent clinical findings include
asymmetric weakness in both distal and proximal muscle groups, in particular the
quadriceps femoris muscles and wrist and finger flexors (Amato, Gronseth, Jackson,
Wolfe, Katz, Bryan & Barohn, 1996; Arnardottir, Alexanderson, Lundberg & Borg,
2002; Felice, Relva & Conway, 1998; Lotz, Engel, Nishino, Stevens & Litchy, 1989).

In patients with IBM, serum creatine kinase is often elevated, whilst
histological findings include rimmed vacuoles, endomysia! inflammation, betaamyloid accumulation and atrophic fibres (Arnardottir, et al., 2002; Spector, Lemmer,
Koffman, Fleisher, Feuerstein, Hurley & Dalakas, 1997). The rate of progression of
IBM is relatively slow compared to other forms of liM, with muscle weakness
developing insidiously (Felice, Relva & Conway, 1998; Lotz, Engel, Nishino, Stevens
& Litchy, 1989; Mastaglia, Garlepp, Phillips & Zilkd, 2003). This can result in a

diagnosis not being made for several years after the patient initially complains of
symptoms (Phillips, Zilko & Mastaglia, 2000).

The pattern of muscle weakness in IBM patients is primarily the early atrophy
of the quadriceps femoris muscle, which often leads to the patient falling due to their
'knees buckling' or the patient tripping over an obstacle due to their inability to raise
their foot to the height they perceive they are raising it to safely clear the obstacle.
The initial presentation is often due to the patient having experienced a fall or nearfall which the patient has difficulty explaining or justifying why it occurred
(Mastaglia, et al., 2003). The selective pattern of muscle involvement in IBM patients
can result in the clinical diagnosis of the disease (Mastaglia, et al., 2003). However, a
muscle biopsy is . commonly used and is thought to be the definitive diagnostic
process, enabling not only a diagnosis to be made, but it can also indicate the severity
7

of the disease in it's current state and confinn the actual form of myositis that is
affecting the patient (Mastaglia, et al., 2003). The use of magnetic resonance imaging
(MRI) can assist in the confirmation of a diagnosis, in particular if a muscle biopsy is
inconclusive or when atypical muscle involvement is prevalent (Mastaglia, et al.,
2003).

Corticosteroids and immunosuppressive agents are generally accepted as the
medical treatment for patients with IBM, but even short-term benefits from using
these are rare (Isenberg, Allen, Farewell, Ehrenstein, Hanna, Lundberg, Oddis,
Pilkington, Plotz, Scott, Vencovsky, Cooper, Rider & Miller, 2004; Mastaglia, 2000).
Immunoglobulin therapy has been shown to elicit a mild improvement and possibly
slow the disease progression (Amato, Barohn, Jackson, Pappert, Schenk & Kissel,
1994; Dalakas, Sonies, Dambrosia, Sekul, Cupler & Sivakumar, 1997; Soueidan &
Dalakas, 1993). A typical characteristic of IBM is its resistance to the commonly
accepted forms of immunotherapy (Amato et al., 1996; Oldfors & Lindberg, 1999).

It was previously thought that physical exercise should be avoided due to the

concern that it would enhance the inflammatory process (Alexanderson & Lundberg,
2005; Dalakas, 1989; Jones, Newham, Round & Tolfree, 1986). However, studies
have shown physical training of patients with polymyositis (PM) and dermatomyositis
(DM) resulted in muscle strength improvements in the absence of an inflammatory
reaction (Alexanderson, Stenstrom & Lundberg, 1999; Wiesinger, Quittan, Aringer,
Seeber, Volc-Platzer, Smolen & Graninger, 1998A; Wiesinger, Quittan, Graninger,
Seeber, Ebenbichler, Sturm, Kerschan, Smolen & Graninger, 1998B).

Exercise

training programs targeting improvements in muscular strength should include
isotonic, isometric and isokinetic exercises (Aitkens, McCory, Kilmer & Bernauer,
1993; Mastaglia, et al., 2003).

Falling due to lower body weakness and the increased risk of cardiovascular
disease due to reduced mobility are significant health issues that often lead to
disability and a decreased quality of life in IBM patients. Exercise programs can
result in strength gains, prevent strength loss and can be performed without muscular
fatigue or inflammation in IBM patients (Amardottir, et al., 2002; Spector, et al.,
·1997). Physical activity has been shown to be a safe and appropriate enablement
8

strategy in other inflammatory myopathies. Exercise has been shown to improve a
patient's muscular strength and endurance, and importantly, can improve the patient's
well being (Wiesinger, et al., 1998A). There is evidence to suggest exercise could
potentially play an important role in the delaying of the disease progression, with an
investigation into the pattern of muscle weakness in IBM patients presenting
relatively novel findings (Felice, Relva & Conway, 1998).

It was found that

weakness and muscle atrophy in the forearms was particularly more profound on the
non-dominant side of the body. The investigators in this study suggested that daily,
functional activities such as washing, buttoning and writing delay the atrophy and
progressive weakness associated with this muscle disease, and therefore concluded
that performing exercise may result in a delaying of the disease progression (Felice,
Relva & Conway, 1998).

The purpose of this study is to investigate the effectiveness of a functional,
home-based, patient-specific exercise program on muscle strength, endurance and
function in an IBM patient group. The potential of functional exercises to improve
muscle strength and function in the absence of disease progression markers is not well
understood.

It is believed that an exercise program tailored to the individual is

important for the routine management and long-term treatment of the disease.

Integral to this study is the correct prescription of both resistive and aerobic
exercise, in particular the type and amount of the chosen exercises, and the
individuality of the exercise programs to be given to these patients. In undertaking
this study, it was believed that an aggressive exercise program will result in either
non-compliance in the program or excessive muscle fatigue/soreness leading to
withdrawal from the study. Consequently, the patient specific exercise programs that
were prescribed to the IBM patients were initially very conservative to account for
these important issues and to ensure the technical aspects of the exercises are learnt so
that the patient employed the correct technique and applied the adequate loading onto
their muscles.

9

2. Literature Review

2.1 Idiopathic Inflammatory Myopathies

Idiopathic Inflammatory Myopathies (liM) is a diverse group of disorders with
various clinical and pathological presentations that are typically characterised by
muscle weakness and chronic muscle inflammation (Oddis, Rider, Reed, Ruperto,
Brunner, Koneru, Feldman, Giannini & Miller, 2005; Phillips & Mastaglia, 2000).
Mastaglia, Phillips and Zilko (1997) report the cause of some liM's to be "identifiable
viral, bacterial, fungal, or parasitic micro-organisms". They can be localised and
restricted to a single muscle, or extensive and involve a range of skeletal muscles
(Mastaglia, · et al., 2003).

Three common forms of liM's are polymyositis (PM),

dermatomyositis (DM) and inclusion body myositis (IBM), and each has distinctive
clinical, histological and pathological manifestations (Bohan & Peter, 1975; cited in
Isenberg, et al., 2004; Mastaglia, et al., 2003). Idiopathic inflammatory myopathies
are immune-mediated myopathies which can occur in isolation, in conjunction with
other autoimmune disorders or with connective tissue disorders (Mastaglia, et al.,
2003).

2.2 Inclusion Body Myositis

Originally developed in 1971 (Yunis & Samaha, 1971; cited in Tawil &
Griggs, 2002), the term 'inclusion body myositis' was applied to an idiopathic
inflammatory myopathy variant clinically and pathologically different to other known
myopathies. Yunis and Samaha (1971; cited in Derk, Vivino, Kenyon & Mandel,
2003) used it to describe a patient with abnormal tubular filaments found within
muscle fibres on electron microscopy.

It was further elaborated on in 1978 by

Carpenter, Karpati, Heller and Eisen (1978; cited in Derk, et al., 2003) who found
distinguishing features to dissociate it from polymyositis and dermatomyositis.
'Inclusion' refers to the inclusion bodies found in the prominently affected muscle
cells, whilst 'myositis' is an acknowledgement of the inflammation that is found in
the involved muscles.

IBM is the most·common inflammatory myopathy in individuals over the age
10

of 50, and is believed to be more common in males (Felice, Relva & Conway, 1998;
Lotz, Engel, Nishino, Stevens & Litchy, 1989; Oldfors & Lindberg, 1999; Phillips,
Zilko & Mastaglia, 2000). In a 10-year retrospective study on the prevalence of IBM
in Western Australia, Phillips, Zilko and Mastaglia (2000) reported the prevalence of
IBM to be 9.3 per million population in Western Australia (using population figures
adjusted for sex, the gender differentiated figures were 10.9 and 7.7 for males and
females respectively per million). Due to the diagnostic process, the time differential
between the onset of symptoms and diagnosis, and the chronicity of the disorder, the
authors acknowledge their figures to most likely be an underestimation and conclude
that further population studies are required

Ninety five IBM patients were identified in a study in The Netherlands, with
43 males and 21 females comprising 'the subject population (31 were unable to
complete the

study for various reasons)

(Badrising, Maat-Schieman, van

Houwelingen, van Doom, van Engelen, Faber, Hoogendijk, de Jager, Koehler, de
Visser, Verschuuren & Wintzen, 2005). Badrising, Maat-Schieman and van Duinen
(2000) estimated the prevalence of IBM in.The Netherlands to be 4.9 per million
population (the investigators thought this to be an underestimation though). However,
in respect to the two described studies, different criterion was used to diagnose the
IBM, which may affect the resultant prevalence figures. Worldwide figures of the
prevalence of IBM are unknown, and certainly more research is required to
systematically determine how common IBM is, and to account for other
epidemiological aspects of the disease.

2.3 Clinical Presentation

A slowly progressive muscle disease of insidious onset, muscle weakness in
IBM patients is typically selective, with initial atrophy and weakness found in the
quadriceps femoris muscles in the lower limbs (Mastaglia, et al., 2003; Oldfors &
Lindberg, 1999; Tawil & Griggs, 2002). The weakened knee extensors, and the falls
they predispose the patient to, are often the initial presenting symptom of IBM
(Mastaglia, et al., 2003). The forearm flexors are also selectively involved in the
earliest stages of the disease progression, in particular the flexor digitorum profundus
muscles, resulting iri a'n increasing difficulty in maintaining flexion of the distal
11

phalanges when the patient is performing a task requiring grip strength (Mastaglia, et
al., 2003).

Phillips, Cala, Thickbroom, Melsom, Zilko and Mastaglia (2001) suggest the
involvement of the medial gastrocnemius is also typical of IBM. Finger extensors,
thumb hyperextension and flexor digitorum sublimis gradually become involved,
along with the more proximal muscles in the upper limbs (Mastaglia, et al., 2003).
Difficulty swallowing has also been recorded by IBM patients due to the involvement
of pharyngeal and oesophageal muscles (Badrising, et al., 2005; Mastaglia, et al.,
2003; Ranque-Francois, et al., 2005; Tawil & Griggs, 2002).

Atypical patterns of muscle involvement are not rare, with a more proximal or
asymmetric pattern of muscle involvement having been reported (Lindberg, Persson,
Bjorkander & Oldfors, 1994). This is supported by a study by Phillips et al (2001)
which concluded that the common pattern of muscle involvement is not always the
case in IBM patients. Whilst it has been widely acknowledged as being the most
common myopathy in individuals over the age of 50 (Ranque-Francois, et al., 2005;
Sivakumar & Dalakas, 1997; Vogel, 199S), a study by Badrising et al (2005) reported
the onset of symptoms to be generally after the age of 40 as a common characteristic.
There is often a substantial time differential between the onset of symptoms and
actual diagnosis, with Phillips, Zilko and Mastaglia (2000) reporting an average delay
of 4.4 years.

2.4 Etiology

The etiology of IBM is largely unknown (Tawil & Griggs, 2002). Clinically,
IBM has been linked to mild increases in other systemic autoimmune disorders and
there is strong evidence to suggest it is an immune-related disease (Tawil & Griggs,
2002). Mastaglia, Phillips and Zilko (1997) support this by claiming in IBM "cellular
immune mechanisms have been directly implicated in causing the muscle fibre
injury".' Cytotoxic CDS+ T-cells are prominent within endomysia! infiltrations, major
histocompatibility complex (MHC) class 1 expression by muscle fibres, and the
infiltration of non-necrotic fibres by CDS+ lymphocytes and macrophages are
typically found atthe cellular level (Mastaglia, Phillips & Zilko, 1997; Mastaglia, et
12

al., 2003; Ranque-Francois, et al., 2005; Tawil & Griggs, 2002).

The muscle tissue of an IBM patient exhibits pro-inflammatory cytokines
interleukin-1 (IL-1a), interleukin H1 (IL-1/3), interferon-'¥, lymphotoxin and tumour
necrosis factor (TNF -a) predominantly produced by macrophages and monocytes
(Lundberg, 2000; Lundberg & Nyberg, 1998; Mastaglia, et al., 2003). These play
important roles as up-regulating and down-regulating factors of molecules integral to
the homing process of inflammatory cells to the tissue (Lundberg & Nyberg, 1998).
Cytokines can perform functions such as T-cell activation, lymphocyte and
mononuclear

phagocyte

recruitment,

stimulation

of expression

of major

histocompatibility complex molecules and potentially can directly damage target cells
(Mastaglia,- et al., 2003). These functions can then aid in the generation or further
enhancement of autoimmune responses and assist in the local inflammatory response
(Mastaglia, et al., 2003).

Inflammatory inhibiting cytokines, such as transforming growth factor-/3 and
interleukin 4 (IL-4), have been found in idiopathic inflammatory myopathies
(Lundberg, 2000).

Chemotactic and inflammatory chemokines have also been

observed in liM's, including monocyte chemoattractant protein-1

(MCP-1),

macrophage inflammatory protein-1a (MIP-1a) and regulated-upon-activation normal
T-cell expressed and secreted (RANTES) (Confalonieri, Bernasconi, Megna, Galbiati,
Cornelio & Mantegazza, 2000; Lundberg, 2000; Mastaglia, et al., 2003).

The presence of T-cell receptors in the incursive lymphocytes indicates a
possible case of restrictive gene rearrangements, raising the prospect that the T-cell
activation is due to a potential superantigen (Lindberg, Oldfors & Tarwoski, 1994;
Tawil & Griggs, 2002).

The persistence of this pattern throughout the disease

progression implies that the primary antigenic stimulus continues to cause the
immune-mediated muscle disease post-presentation of the initial symptoms (Tawil &
Griggs, 2002).

However, the absence of

~long

term and complete responses to

immunosuppressive agents indicates that there maybe more to the cause of IBM than
the immune-mediated etiological belief (Tawil & Griggs, 2002).

Abnormal. accumulation of proteins, including beta-amyloid, within the
13

vacuolated muscle fibres is commonly reported in IBM patients, however, it is unclear
as to what initiates their deposition and whether or not they result from or cause the
inflammatory process (Askanas & Engel, 2003; Derk, et al., 2003; Tawil & Griggs,
2002).

The relationship between these accumulated proteins and immune

mechanisms prevalent in IBM patients is unknown (Mastaglia, Phillips & Zilko,
1997). Evidence of nitric oxide induced oxidative stress, the contributions of genetics
and the possibility of the overexpression of dB-crystallin in IBM patients further
confounds the process of establishing a definitive etiology for this inflammatory
myopathy (Alexanderson & Lundberg, 2005; Mastaglia, et al., 2003; RanqueFrancois, et al., 2005; Tawil & Griggs, 2002).

Early and accurate diagnosis is important to guide the treatment process and
enable a definitive prognosis to be made as early as possible. This is particularly
important when distinguishing the various forms of idiopathic inflammatory
myopathies, as PM/DM often respond favourably to treatment, whilst IBM has been
shown to be quite resistant to various therapeutic interventions (Mastaglia, et al.,
2003; Mastaglia, Phillips & Zilko, 1997; Ranque-Francois, et al., 2005).

IBM patients have a selective pattern of muscle involvement of the quadriceps
femoris muscles and the forearm flexors of the upper limbs (Phillips, et al., 2001).
The greater susceptibility of some muscles to the muscle disease IBM is currently an
unresolved issue.

Phillips et al (2001) lists possible reasons for this selectivity,

including muscle size differences, fibre-type proportions, physiological roles and
functional reserve of different muscles, and the possibility of an accumulation of
mutant DNA deletions that occur with ageing. This characteristic muscular selectivity
can be more difficult to identify in the latter stages of the disease, and atypical
patterns of muscle involvement and asymmetric weakness have been found
(Mastaglia, Phillips & Zilko, 1997).

The insidious onset of proximal and distal

weakness in an individual over the age of 50 should raise initial suspicions of IBM
(Ranque-Francois, et al., 2005)

As a prominent .marker of muscle damage, elevated serum creatine kinase
14

(CK) has been used to support the diagnosis of IBM, however normal or slightly
elevated levels of CK are typically found in IBM patients (Badrising, et al., 2005;
Derk, et al., 2003; Mastaglia, Phillips & Zilko, 1997; Ranque-Francois, et al., 2005;
Tawil & Griggs, 2002). The extent and severity of the myositis can be indicated by
electromyography, but ultimately, a muscle biopsy is the most definitive standard in
providing a conclusive confirmation of IBM (Derk, et al., 2003; Mastaglia, et al.,
2003; Mastaglia, Phillips & Zilko, 1997; Tawil & Griggs, 2002). A muscle biopsy
should ideally be performed prior to the commencement of treatment and will not
only allow confirmation of the diagnosis but will also provide an insight into the
severity and extent of the muscle inflammation and exclude any other forms of
myopathies {Mastaglia, Phillips & Zilko, 1997; Mastaglia, et al., 2003).

An open biopsy is preferable, and using magnetic resonance imaging (MRI) to

assist in selecting a biopsy site may prevent a potential sampling error that could
possibly interfere with the identification of characteristic clinical features or if the
clinical picture is not obvious (Mastaglia, et al., 2003; Oldfors & Lindberg, 1999).
The muscle biopsy should identify a number of features, including endomysia!
inflammation and invasion of non-necrotic fibres, rimmed vacuoles and intracellular
amyloid deposits (Tawil & Griggs, 2002). The presence of these features provides a
definite diagnosis of IBM, and other clinical and pathological criteria are not required.
Griggs, Askanas, DiMauro, Engel, Karpati, Mendell & Rowland (1995) developed a
distinct criteria to enable diagnosis that took into consideration typical biopsy findings
to allow rapid diagnosis, and also other clinical and laboratory features (refer to
Appendix B) that enable diagnosis despite possible atypical muscle involvement or
the absence of the primary clinical diagnostic features (Refer to Appendix B for the
diagnostic criteria of IBM)

2.6 Treatment
The treatment of Inclusion Body Myositis can be considered to currently be a
work in progress (Arnardottir, et al., 2002; Ranque-Francois, et al., 2005).

The

unknown etiology of the disease presents clinicians with a challenging task in
developing strategies or therapeutic measures to treat IBM.

The current options

· available to patients are all non-selective in relation to their impact on the immune
15

system (Mastaglia, et al., 2003; Mastaglia, 2000).

It has been shown that the

conventional method of pharmacological treatment prescribed to IBM patients often
has little, if any effect, on the progression of the disease (Alexanderson & Lundberg,
2005; Griggs & Rose, 1998). However, most IBM patients are initially placed on a
course of medication, such as a corticosteroid (most commonly prednisone) and an
immunosuppressive agent, such as methotrexate, to combat the disease to some
degree, with the patient's responses to these drugs varying greatly (Mastaglia, 2000).

Immunoglobulin therapy has been trialled previously, with findings to suggest
it could play a role in the treatment of the muscle disease (Mastaglia, Phillips and
Zilko, 1998; Soueidan & Dalakas, 1993). A slowing of the disease and possible
moderate improvement has been reported in a number of short-term studies (Amato,
Barohn, Jackson, Pappert, Sahenk & Kissel, 1994; Dalakas, et al., 1997; Soueidan &
Dalakas, 1993; Walter, Lochmuler, Toepfer, Schlotter, Reilich, Schroder, MullerFelber & Pongratz, 2000). In a study by Mastaglia, Phillips and Zilko (1998), muscle
myometry scores improved following intravenous immunoglobulin (IVIg) in some
cases, however, only slight functional improvements were observed, and on the basis
of this, it can be difficult to justify considering the expensive nature of the treatment
(Mastaglia, Phillips & Zilko, 1998).

Other forms of therapy have been proposed, including, L-camitine, coenzyme
Q, antioxidants and testosterone, but are yet to be clinically assessed (Engel &

Askanas, 1998). Despite the uncertainty regarding various drug therapies and their
ultimate effect on IBM patients, these treatment modalities deserve further research in
the form of multi-centre, long-term, randomized, placebo-controlled therapeutic trials
(Mastaglia, 2000; Walter, et al., 2000). Exercise therapy has been trialled with some
positive results for IBM patients in the absence of disease progression markers
(Amardottir, et al., 2002; Spector, et al., 1997).

2. 7 Exercise and IBM

2. 7.1 Strength Training

Strength training in otherwise healthy individuals is well established as a
means of increasing muscle strength, endurance and size (Feigenbaum & Pollock,
16

1999), but it can also play an important role in the rehabilitation of patients with
neuromuscular disorders (McCartney, Moroz, Garner, McHomas, 1988; MilnerBrown & Miller, 1988; Spector, Gordon, Feuerstein, Sivakumar, Hurley & Dalakas,
1996).

Phillips and Mastaglia (2000) have demonstrated its benefits in the

management ,of various myopathies; however, its presence in the long-term treatment
and clinical management of inflammatory myopathy patients is not well understood.
Further research is required in regards to the establishment of training protocols that
will optimally induce muscle strength, endurance and functional changes, and the
development of outcome measures that are suitably sensitive, and provide reliable and
valid results in assessing the impact of exercise as a therapeutic means in
neuromuscular disordered patient groups (Mastaglia, et al., 2003).

The repetitive

nature of resistance training should not prevent the patient's muscles from responding
positively to the strength tasks (Taivassalo, De Stefano, Chen, Karpati, Arnold &
Argov, 1999).

Two key studies provide the current basis of knowledge in regards to the
effect of an exercise training program on IBM patients. These investigations were
warranted on the basis of positive findings from physical training in PM/DM patients
and other myopathic patients.

Wiesinger et al (1998A) found significant

improvements in muscle strength, oxygen uptake and overall wellbeing.

The six

week training intervention also saw improvements in 'activities of daily living'
(ADL) scores, whilst there was no significant increase in disease activity compared to
the control sample.

Wiesinger et al (1998B) reported a clinically significant increase in the aerobic
capacity of the sample population. Peak oxygen uptake, peak isometric torque in the
lower extremities and ADL scores all rose to significant levels in the absence of a rise
in serum creatine phosphokinase (CPK). The six-month study included a combination
of stationary cycling and step aerobics, as did the earlier study by Wiesinger et al
(1998A). However, the duration of the 1998A study (6 weeks) and the sample size of
the later study (1998B) (n=8) must be considered when analysing their results.

Alexanderson,

Stenstrom

and

Lundberg

(1999)

performed

a

study

· investigating the .effects of a home exercise program on PM/DM patients, with
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positive results reported. In accordance with the Functional Index (FI) scale, six of
ten cases were found to have significantly improved muscle function in the absence of
a rise in CPK. Tre remaining four patients all reported functional improvements.
Muscle biopsies and MRI' s were also used to confirm the safety of the exercise
program in terms of monitoring potential muscle inflammation as a result of the
exercises performed.

The Short Form-36 (SF-36), which is a widely used assessment tool in
inflammatory myopathy studies (Isenberg, et al., 2004), was used to assess changes in
health and wellbeing, and significant improvements in health status were found as a
result of the exercise program. Various other investigations have been performed to
assess the· impact of exercise, in particular strength-training programs, on patients
with myopathies (Phillips & Mastaglia, 2000). Despite the small sample sizes that are
prevalent in the majority of these studies, muscle strength improvements are typically
seen as a result of various exercise protocols and training periods.

An investigation into the asymmetrical patterns of muscle weakness and

atrophy observed in IBM patients suggests that exercise may potentially delay the
progression of the muscle disease (Felice, Relva & Conway, 1998). The study found
the non-dominant forearm flexor was significantly more atrophied and weaker than
the dominant forearm flexor. From this, the investigators concluded that dominant
side, daily activities, such as writing, washing and buttoning, delay the progression of
the disease, and evidence of less pronounced atrophy in other groups that rarely
perform unilateral exercises support this conclusion (Felice, Relva & Conway, 1998).
The investigators recommend the prescription of moderate resistant exercise, in
particular targeting the weakened forearm flexors and quadriceps muscles, and
acknowledge the need for further studies in this area (Felice, Relva & Conway, 1998).

Spector et al (1997), conducted a 12-week progressive resistance strengthtraining program, primarily designed to target the predominantly weakened muscles
in 5 IBM patients.

The exercise program was prescribed with upper and lower

extremity exercises alternated between exercise sessions to minimize fatigue, and
suitable recovery .periods, and volumes and intensities of workload were chosen.
These 'training' variables were prescribed on the basis of previous resistance training
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studies in a Post-Polio Muscular Atrophy patient group, in which dynamic muscle
strength increased following a 10-week progressive resistance strength training
program (Spector, Gordon, Feuerstein, Sivakumar, Hurley & Dalakas, 1996).

The investigators also minimised the eccentric phase of the chosen activities.
Resistance training exercises cause damage to the muscle, but in an otherwise healthy
population, neural adaptation and muscle hypertrophy occur as a result of this, and the
muscles repair and regrow to become larger and stronger (Sale, 1988). Eccentric
exercises damage the muscle and can disrupt the muscle cell membrane, as evidenced
by the release of serum CK from the damaged fibres (Jones, Newham, Round &
Tolfree, 1986), an increase in cytokines in the muscle (Fielding, Manfredi, Wenjing,
Fiatiarone, Evans & Cannon, 1993) and local inflammation (Fielding, et al., 1993;
Luthi, Howald, Claasen, Rosier, Vock & Hoppeler, 1986).

Concentric exercises

minimise this muscle damage whilst still being beneficial to the patient, such that
muscle strength and size gains typically occur (Hurley, Redmond, Pratley, Trueth,
Rogers & Goldberg, 1995). In this study, the concentric phase of the prescribed
resistance exercises was a particular focus.

Strength assessments, fatigue and

activities of daily living scales, MRI's and muscle biopsies to analyse the
immunochemistry and histopathological changes, and markers of muscle damage
were used as assessment tools to quantify the effect of the training program. It was
concluded from this study that IBM patients are able to safely participate in regular
resistance training in the absence of excessive muscle fatigue, immunological and
histological abnormalities, and strength gains, in particular in the least weak muscles,
can be expected.

Arnardottir et al (2002) investigated the effect of exercise on IBM patients
with their study on the effects of a home-based exercise program on muscle function
and it's implications for the inflammatory response by the muscle.

Seven IBM

patients were subject to a 12-week, 5 days-a-week exercise program designed to be
implemented in the patients home.

Easy and moderate exercise programs were

prescribed to the patients based upon their Functional Index (FI) score, and they
included both resistive exercises, mobility exercises and a stretching routine. The
study also included an aerobic component, with the patients instructed to take a 15minute self-paced walk 5 days a week.
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The prescription of exercises and the

associated training variables was based upon work done on a PM/DM training study
which resulted in positive muscle function effects being observed following the
intervention (Alexanderson, Stenstrom & Lundberg, 1999).

In Arnardottir's et al (2002) investigation, the exercise program was shown to

be a safe treatment option with muscle inflammation and the histopathology of the
disease remaining stable throughout the intervention period. Whilst there was an
absence of significant strength gains across all parameters tested, the program was
well tolerated by the group and there was not a reduction in muscle strength whilst the
patients underwent the exercise training.

The investigators acknowledged

experimental deficiencies and the relatively low intensity of the prescribed exercise
program niay have contributed to the lack of significant data. However, this study
provides further evidence of the delaying capacity exercise may have on the
progression of the disease.

The small sample size's in both studies, the duration of the training periods,
and the absence of statistically significant improvements in muscle function and
strength measures, reductions in fatigue and increases in ADL scores suggests further
research is required before conclusive statements regarding the effect of exercise on
IBM patients can be made. This is acknowledged by both Spector et al (1997) and
Arnardottir et al (2002). However, from their studies it can be concluded that exercise
can be safely tolerated by IBM patients and can be confidently prescribed in the
knowledge it will not lead to a decrease in muscle strength as a result of the training
program.

These studies highlight the need for the development of standardised training
protocols that will lead to optimal gains in muscle strength, endurance and functional
improvements which will, importantly, translate to a higher quality of life and provide
the patients with a greater capacity to perform ADL's. For exercise as an evidencebased, therapeutic intervention to be established and integrated into the daily lives of
IBM patients, further research is required.

Patient-centred, resistance training

protocols, sensitive and reliable outcome measures and disease-specific health status
measures for idiopathic inflammatory myopathy patient groups are areas which
·should be of particular interest in future studies.
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2. 7. 2 Aerobic Exercise

The health benefits derived from aerobic exercise are numerous and farreaching and have been well established, with 30 minutes or more per day the
prescribed amount for disease prevention and the promotion of good health in healthy
individuals (Pate, Pratt, Blair, Haskell, Macera, Bouchard, Buchner, Ettinger, Health
& King, 1995; Pollock, Gaesser, Butcher, Despres, Dishman, Franklin & Garber,

1998). Adaptations in the heart and skeletal muscle systems, disease prevention,
improved respiratory function and overall well-being highlight the importance of
exercise for all individuals, including patients with inflammatory myopathies
(Mastaglia, et al., 2003; Taivassalo & Haller, 2005).

Taivassalo et al (1999)

demonstrated aerobic exercise training can elicit benefits in nonmetabolic myopathies
and mitochondrial myopathies, with significant improvements found in estimated
aerobic capacity, heart rate and blood lactate at submaximal exercise intensities. A
lifestyle change and appropriate physical therapy habits should be the aim in the
prescription of an exercise program designed to attain maximum benefit whilst
minimising the risk to the participant (Pollock, et al., 1998).

These findings are supported by Taivassalo, Shoubridge, Chen, Eng,
Kennaway, Phil, DiMauro, Arnold and Haller (2001) and Taivassalo and Haller
(2005). However, as Taivassalo and Haller (2005) and Taivassalo et al (1999) have
stated in regards to patients with mitochondrial myopathies and other various
neuromuscular disorders, exercise intolerance can be a prominent manifestation of the
muscle disease and the reduced activity level of the IBM patient. Characterised by
fatigue at low exertion levels, weakness of active muscles and lactic acidosis, the
resultant deconditioning and increased functional limitations not only further
emphasises the individual's sedentary lifestyle, but also increases the risk of disease
(Taivassalo & Haller, 2005; Trenell, Sue, Kemp, Sachinwalla & Thompson, 2006).

The muscle weakness, reduced endurance and increased fatigue which tend to
dominate the lives of patients with inflammatory myopathies are impairments which
negatively affect the patient's quality of life, independence and general health and
well-being (Phillips & Mastaglia, 2000). The reduction in aerobic capacity results in
the patient's mobility. being severely affected and subsequently cardiac and
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respiratory function is impaired, putting the patients at an increased risk of
cardiovascular disease (Alexanderson & Lundberg, 2005; Hebert, Byrnes, Baethage,
Wolf & Kinasewitz, 1990).

Wiesinger, Quittan, Nuhr, Volc-Platzer, Ebenbichler, Zehetgruber and
Graninger (2000) reported PM/DM patients to have reduced peak oxygen uptake
values compared to age and sex-matched controls. It was concluded from this study
that a number of factors possibly contribute to why PM/DM patients are aerobically
impaired; including the sedentary lifestyle the disease tends to impart upon the
patient, cardiac involvement, pulmonary involvement or muscle atrophy or
inflammation as a result of the disease. Whilst further clarification is required to
determine the primary cause of their reduced aerobic capacity, it was shown that a
carefully constructed, exercise testing regimen can be safely used to determine the
aerobic capacity of myositis patients.

Wiesinger et al (1998B) reported an aerobic capacity increase following their
physical training program in PM/DM patients.

Using a patient-specific cycling

protocol, the patients combined this with a step aerobics exercise session to develop
their aerobic capacity. The use of the cycling protocol to aerobically train the patients
was justified by the investigators on account of the concentric exercises causing less
muscle damage than eccentric exercise (this is when the active muscle is lengthened).
(Wiesinger, et al., 1998B). The patient's aerobic capacity was increased by 28%,
which was a significant improvement. A 9% reduction in resting heart rate was also
found, whilst the ventilatory threshold of the patients was increased by 8%, which
was another statistically significant result.

Hicks, Drinkard, Summers and Rider (2002) found similar findings in their
study into the effects of aerobic exercise in juvenile DM patients. Taivassalo et al
(1999) demonstrated an aerobic exercise program can provide physiological and
functional benefits in the absence of disease progression markers in chronic myopathy
patients·. Taivassalo et al (1999) reported positive adaptations from a patient-specific
training program that was prescribed at low intensities, but acknowledged the longterm effects of an .aerobic exercise program was yet to be established. Exercise as a
therapeutic intervention· has been shown to improve balance in the elderly, and with
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falling a major risk factor in IBM patients, improvements in balance that will reduce
the risk of falling is desirable (Barnett, Smith, Lord, Williams & Baumand, 2003).

Numerous other studies have been conducted in assessing the impact of an
aerobic training program on patients with various forms of myopathies, with generally
positive results having been found. Aerobic capacity, maximum V02 consumption
and exercise tolerance has been demonstrated to improve to significant levels
following an aerobic exercise program (Phillips & Mastaglia, 2000). Phillips and
Mastaglia (2000) question the relative importance of the duration of the training
period, stating that there may not be any additional benefit of implementing a longer
training period (>24-weeks) in comparison to a short-term program (>6-weeks).
Rather, the intensity of the exercise may have a greater influence on the resultant
aerobic capacity changes. To date, there is an absence of information regarding the
effect of aerobic exercise training on IBM patients.
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3. Materials & Method

3.1 Study design

3.1.1 Patients

Seven Patients (2 women and 5 men, mean age 66. 7±6.2 years) with IBM
were recruited from the Australian Neuromuscular Research Institute at Sir Charles
Gardiner Hospital, Perth, Western Australia. Diagnosis was confirmed by clinical and
histological findings, and all have been in a state of progressive decline in muscle
strength and function, and overall functional ability, for 5-9 years. This study had
ethical approval from Sir Charles Gardiner Hospital and Edith Cowan University, and
the each patient signed an informed consent prior to the beginning of this study (refer
to Appendix C).

3.1.2 Experimental Design

Clinical examination, muscle strength and function assessments, and a
maximal aerobic exercise test were conducted prior to a 12-week exercise training
intervention. Serum CK levels were assesse,d pre- and post-training intervention as
part of the patients' routine management. A Penny and Giles Transducer hand-held
myometer (refer to Appendix F) was used to ascertain the patients muscle strength in
the following movements bilaterally: shoulder abduction/external rotation, elbow
flexion/extension, wrist extension, hip abduction/flexion, and knee flexion/extension.
As per Figure 1, trained/untrained movements were tested pre and post intervention in
diseased and healthy muscles. Grip strength was also measured using a Spiedel and
Keller, Stabil 3 grip dynamometer.

Functional tasks evaluated were walking 30

meters unaided, walking up one flight of stairs (11 steps) (Refer to Appendix D for
muscle assessment recording worksheet and Appendix E for strength assessment
positions for hand-held myometry).

Standard instructions and levels of positive

reinforcement were implemented throughout the testing occasions for each patient,
pre- and post-training intervention.

The patients were also required to fill out the SF-36 instrument to ascertain
potential changes in the patients overall health status as a result of the intervention
(refer to Appendix G fot· a sample SF-36). Each patient undertook a maximal aerobic
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exercise test on a stationary bike, with the Metamax 3B portable V02 system utilised
to assess their aerobic capacity. Each patient undertook a familiarisation session prior
to the initial test, whereby the patient was prepared with a standard 5-lead ECG and
equipped with the Metamax 3B system harness. Resting heart rate (RHR) (beats per
minute [bpm]) and blood lactate levels (taken via the fingertip) was taken from the
patient, whilst the Borg 0 - 10 Rating of Perceived Exertion (RPE) scale (Borg,
1982), which was to be used at one minute intervals during the test to monitor the
patient's exertion levels, was explained to the patient. The patient was advised to
cease the test if they felt unwell for any reason, and this was reinforced by the
supervising Doctor who attended the test to ensure a safe test was being conducted
and no undue stress was being placed on the patient.

Due the variability in the aerobic capacity of each patient within the patient
group, the protocol for the aerobic exercise testing was individualised based on the
patients' familiarisation tests, but only with regards to the wattage amount the patients
were to increase every two minutes. Common to the entire patient group was the
initial starting load of 20 Watts (W), the timing of the incremental increases in
wattage (every two minutes of the test), and the maintenance of a cycling cadence
between 40 and 50 revolutions per minute (RPM). The testing protocol was based on
similar research previously applied in inflammatory populations (Jeppesen, Olsen &
Vissing, 2003; Trenell, et al., 2006) and preliminary tests completed by a number of
the IBM patient's. V02 (ml/kg/min- 1) peak, heart rate (bpm), blood lactate (mmor 1)
and RPE were recorded for analysis and cardiac rhythm was monitored during the test
for safety purposes by the trained Doctor in attendance. The tests were performed in
the cardio-pulmonary department of Sir Charles Gardiner Hospital, administered by a
trained Honours student and a laboratory technician.

3.1.3 Training Program

Each patient undertook a home-based, patient-specific 12-week exercise
program integrating stretching exercises, resistance exercises and an aerobic
component. The patients' were very gently overloaded in the early stages of the
program to encourage compliance and gradual adaptation, and to prevent
'overtraining' in the initial stages of the program. The total amount of exercise
prescribed per week, which will be referred to as the training load, comprised the
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number of repeated sets, duration of recovery period between exercises, and number
of exercises per week. To begin with, the load prescribed was very light in order to
assess the patients tolerance to the tasks assigned, ensure the correct techniques and
movements were employed and to monitor the patients' compliance to the overall
program.
The patients were presented with an exercise booklet (refer to Appendix H),
containing illustrations and exercise descriptions, which entailed the range of
stretches and exercises the patient could potentially perform during the intervention
period.

Exercises were selected that emphasised patient function, and so where

possible, multi-joint exercises were preferentially used as opposed to single-joint and
movements were performed in functional positions involving balance and stabilizing
aspects. Where functional and body weight exercises were considered too difficult,
isometric, single joint muscle contractions were performed (American College of
Sports Medicine, 2003, p.243).

A range of stretches was prescribed on the basis of increasing joint mobility
and improving the patients' muscular flexibility, with particular attention paid to the
wrist and finger flexors and extensors which are prominent areas of weakness and
exhibit a reduced range of motion in this clinical population. The patients were given
approximately 6-8 different stretches to perform, with 2-3 sets to be performed of
each exercise and for either 10-15 breaths, or a specific number of repetitions as
assigned by the investigator. Counting by number of breaths was encouraged to avoid
the patients holding their breaths, which can occur during resistance training
exercises, particularly when performing isometric exercises in older trainees (Fleck &
Kraemer, 2004, p.21). Exercise selection was patient-specific and prescribed based
upon observation of the patient's ability to perform certain movements and areas of
reduced joint range ofmotion. The patient's were instructed to perform their selected
stretches once daily.

The resistance exercises were selected on an individual basis and were also
prescribed upon observation of the patients' ability to perform various functional
movements. Exercises were selected or modified such that between 8-15 repetitions
could be . performed; then two repetitions less than the maximum number of
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repetitions the patient could perform during the initial assessment was prescribed.
The exercise program was separated into upper and lower extremity components, with
approximately 3 exercises performed 2-3 times each (separated by 3-4 minutes rest),
once daily, 3 times per week. With the aerobic component of the patients exercise
program to be performed 3 times per week, the patients were encouraged to perform
the resistance exercises and the aerobic training on separate days. Accordingly, the
patients were to perform the upper and lower extremity exercises on the same day, but
to avoid overloading the patient's, the two components of the resistance exercises
were to be performed separately, with one component to be trained in the morning,
and then one later in the day. This was to prevent overtraining and enable the patient
to recovery between tasks. The patients were also instructed to have one day of rest
each week. A study by Kilmer, Wright and Aitkens (2005) on the impact of a homebased physical activity and dietary intervention in people with neuromuscular diseases
supports this conservative approach.

The exercises the patients were to perform were initially demonstrated to
them, and then performed by the patient themselves under supervision to ensure the
correct techniques and movements were being employed.

This also allowed the

investigator to evaluate the patients' current levels of muscular strength, endurance
and function and to prescribe exercise volume and frequency that would slightly
challenge the patient, but would also be achievable. Specifically, mild increments in
training load were scheduled fortnightly, although modified according to patient
tolerance and compliance. Patients were instructed that if the exercise became 'easy'
during a given two week period, they could increase the number of repetitions by a
maximum of four, for each exercise. The scheduled load increments did not increase
all variables simultaneously, but one variable in a given fortnight, and in the
following order: exercise number (increased to

~4-6

exercises), then number of

repetitions (15 maximum), and lastly, number of sets (maximum of 3). The patients
were also asked to contact the investigator to inform them of any program changes
when they occurred.

The aerobic component of the training program involved the patients cycling
on a Monark Ergomedic 894E stationary cycle ergometer at an intensity
corresponding to 80% ·of their maximum heart rate achieved during thdr maximal
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aerobic test (Taivassalo, De Stefano, Argov, Matthews, Chen, Karpati & Arnold,
1998).

Polar A3 Heart rate monitors to enable the patients to exercise at the

prescribed intensity were borrowed by the patients from the Edith Cowan University
Sports Science Department for the duration of the training period.

Volume and

frequency of this component of the patients exercise programs was individually
assessed and administered in consultation with Senior Physicians at the Hospital. The
patients were instructed to cycle 3 times per week, and progression of the patients'
aerobic training component was achieved in much the same way as the resistance
training component of their exercise program. If the patient felt the cycling became
too 'easy', they were instructed to increase the duration for which they were cycling
at, with a maximum increase of 2 minutes for any fortnightly period. This subscribes
to the basic aim of this program, which was to have the patients exercising at greater
frequencies and lower intensities to induce optimal strength and functional gains
(American College of Sports Medicine, 2000, p.145).

3.1.4 Program Monitoring

This consisted of fortnightly phone calls; the patients' maintaining their
scheduled visits to their specialist at the clinic, and a 'training diary' was given to the
patient to fill out daily. A diary template (refer to Appendix I) was provided for the
patient to record certain training information and subjective feelings related to their
training performance. This included daily recordings of exercise data, such as the
specific exercises undertaken by the patient and the training load they subscribed to.
The investigator also asked the patients' to record in their diaries subjective feelings
of fatigue, soreness and breathlessness immediately following the completion of the
daily exercises, and also each morning of each day. These ratings were based on a 1
to 10 visual analogue scale, with '1' being 'no fatigue, soreness or breathlessness at
all' and ' 10' representing 'extreme fatigue, soreness or breathlessness'. The patients
were also asked to provide a rating of perceived exertion (RPE) of each exercise
session they completed, which was based on the Borg 0-10 scale (Borg, 1982),
immediately following the conclusion of each session. Any incidence of falls or near
falls, and why, was to be recorded by the patients, and they were encouraged to
provide any other information they felt necessary to disclose that may have impacted
on their ability to perform the exercise program. Presentation of the training program
was conducted through· a home-visit by the investigator. At the conclusion of the
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training intervention period, all parameters of muscle strength and function were
reassessed, and the patients also undertook follow-up testing of their maximal aerobic
capacity.

3.2 Data Analysis

Muscle strength and function was compared pre and post a 12-week exercise
training intervention and analysed in both group and individual data sets. Pre and
post data was averaged and tested for normality using the Kolmogorov Smimov test
before a paired two sample t-test was applied for each subject and muscle action. For
each subject, the post-intervention score was normalised to pre-intervention values,
averaged across all subjects and represented by means and standard error (±SE). The
exercise program included the training' of both diseased and non-diseased muscles,
and the investigation used both within-subject and within-study controls to evaluate
the effect the exercise program had on the various muscle groups tested. The lack of
compliance to the exercise program by two of the patient group resulted in an
additional analysis being utilized in this study.

Thus, a comparison between the

compliant (n=5) and non-compliant (n=2) patient groups (compliance defined as
adhering to the exercise program and performing the prescribed exercises for greater
than 70% of the training period) evolved during this study.
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4. Results

Mean group data normalised to pre-training levels shows that the diseased
muscle in the absence of training experienced a decrease in strength levels, as shown
by the 19.6±10% (mean±SE) decline in grip strength (Figure 1). Yet, the healthy,
untrained muscle (shoulder external rotation) experienced maintenance, or in this
case, a slight increase in strength (4.2±6%). With training however, the diseased
muscle, having undergone exercise training, maintained its strength (knee extension
[100.9±10%]), whilst significant improvements (p < 0.05) were observed in otherwise
healthy, trained muscles, with hip abduction strength improving by 59 .1±31 %,
shoulder abduction strength increasing by 66.1±12% and hip flexion strength
increasing by 83.7±35%.

A comparison between the compliant (n=5) and non-compliant (n=2) patient
groups that evolved during this study shows the substantial difference the training
intervention had on the patients muscle strength (Figure 2).

Normalised to pre-

training levels, the compliant patient group experienced a mean increase in muscle
strength across all trained muscles tested of 38.4±12%, and there was a significant
difference (p < 0.05) in improvement when compared to the non-compliant subset of
patients. The non-compliant group that trained infrequently showed an overall mean
increase in muscle strength of 12.2±9%.

Table 1 presents a breakdown of the compliant patients mean muscle strength
data pre and post training, accounting for a sample of a number of distinct subsets of
muscles tested, including diseased and otherwise healthy muscles, and, trained and
untrained muscles. This table shows the respective one and two-tailed p-values for
the sampled muscles. The two-tailed p-values were assigned to the muscle subsets
that cannot be hypothesized as increasing in strength as a result of the exercise
training due to either the muscles being diseased or untrained.

Whereas, the

healthy/trained muscles were assessed by one-tailed p-values in support of the
hypothesis that an otherwise health muscle should increase in strength following a
period of exercise training. It can be observed from the table that shoulder abduction,
hip flexion, hip abduction and knee flexion all resulted in significant improvements
·by the group.
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In assessing the impact of the exercise intervention on a single, compliant
patient, there was a significant difference (p < 0.05) between mean pre and post scores
for all trained muscles (Figure 3a). The patient improved from an average of 5.9±0.6
Kg-fpre-training to 7.3±0.8 Kg-fpost-training. The mean change in muscle strength
for all muscle's involved in training following the exercise intervention of a single,
non-compliant patient is shown in Figure 3b, and it can be seen that the patient
experienced a mild decrease in muscle strength having not completed the exercise
training.

The patients muscle strength averaged 12.7±1.2 Kg-f post intervention,

slightly lower than the mean muscle strength pre-intervention (13.2±1.3 Kg-f).

Group stair climb and walk time/pace number data are presented in Table 2. It
can be seen from this table that whilst there was not a statistically significant
improvement in any of the functional tasks, on average, the patient group improved in
all tasks.

It can be seen that the patients developed a larger amplitude gait as

indicated by the reduction in the number of paces used to complete the 30m walk.
The sample size used in this study should be considered as possibly a contributing
factor that affected the power of the statistical analysis.

The functional improvements of a single compliant patient are illustrated in
Figure 4, with the patient's time taken to complete both the stair climb and 30m walk
reduced following the exercise training period.

The patient completed the post-

intervention stair climb in 39 seconds, an improvement of over 64% on their pretraining effort (64 seconds). Additionally, the patient reduced their walk time by over
95%, with a post-training walk time of 64 seconds compared to a pre-training time of
125 seconds.

The functional deficits experienced by a single, non-compliant patient, as
shown in Figure 5, with time taken to walk 30m and perform a stair climb increased
following the exercise program. The patient's time to climb the 11 steps of the stair
climb increased from 19 seconds to 22 seconds, just over a 13% increase in time
taken. There was an increase in time taken to perform the 30m walk also, with the
patient completing the task in 50 seconds post-intervention compared to 31 seconds
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the patient took pre-intervention, an increase by over 61% in time taken to perform
the task.
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Fig. 1. Mean group data (±SE) of compliant patients (n=5) normalised to
pre-training, showing that in the absence of training, a diseased muscle
experiences a mild strength loss, while a healthy untrained muscle does
not. Yet with training, a diseased muscle can maintain its strength and
other non-diseased muscles can experience a substantial improvement in
strength.

* p < 0.05
** p < 0.001
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Fig.2. Mean group data (±SE), including diseased and
healthy muscles that were involved in the training, normalised
to pre training. There is a significantly greater muscle strength
improvement of trained muscles for the compliant patient
group when compared to the non-compliant patients'
(p < 0.05).
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Table.1. Trained group (n=7) mean (±SE) muscle strength data pre and post exercise
intervention, where P(T <=t) one-tail was used for any healthy/trained muscles, and
P(T<=t) two-tail for any diseased/trained or untrained and healthy/untrained muscles.
* p < 0.05
** p < 0.001

Mean±SE

Shoulder Abduction

Hip Abduction ·
~::;~~Knee Flexion

P-value

Pre

Post

194.57±49.99

182.85±55.32

0.099

8.60±1.46

8.08±1.46

0.435

9.96±1.49

9.00±1.16

0.161

6.77±0.57

6.83±0.48

0.910

7.34±0.96

6.68±0.99

0.125

10.09±1.19

10.28±0.72

0.384

10.25±1.07

16.79±1.68

**0.0005

9.57±0.92

15.09±1.41

*0.008

7.65±1.13

10.17±0.88

*0.009

9.75±1.09

10.56±1.08

*0.02
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Fig.3a). Mean individual data (±SE) of changes in muscle
strength of all trained muscles of a single, compliant patient.
Fig.3b). In the same muscle groups of a non-compliant
patient over this time period, muscle strength remains
unchanged.
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Group (n=7) mean (±SE) functional task data, showing the mean time taken
(seconds) pre and post intervention to perform a stair climb and 30 metre walk, and also
the number of paces used by the patient during the walking task.

Mean±SE

Functional Task

P-value

Pre

Post

Stair Climb

19.4±10.7

15.2±6.1

0.214

30m Walk

43.4±20.4

29.8±8.8

0.160

Paces during 30m walk

67.0±20.0

52.8±7.2

0.170
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Fig.4. Mean (±SE) individual functional capacity data of a single, compliant
participant.
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Fig.5. Mean (±SE) individual functional capacity data of a single, noncompliant participant following the exercise intervention.
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5. Discussion

The present study has shown that a 12-week home-based, patient-specific
functional exercise program performed by the IBM patient, can lead to significant
strength gains in muscles not affected by the disease, the maintenance of strength in
diseased muscle groups and improvements in the performance of functional tasks in
the absence of muscle damage. Figure 1 illustrates the positive impact an exercise
program can have on an IBM patient's muscle strength if they adhere to the training
program as prescribed.

Strength training can result in an increase in strength in

healthy muscles, and can delay the loss of strength in diseased muscles, whilst
functional improvements, despite not reaching statistical significance, could
potentially be viewed as clinically significant improvements for the positive effect
these improvements have on the day-to-day functioning of the patients in this study.

It has been previously thought that exercise programs should be avoided by
patients with inflammatory myopathies due to the concern that the exercise may
enhance the inflammatory process (Alexanderson & Lundberg, 2005; Dalakas, 1989;
Jones, et al., 1986). However, studies in other forms of idiopathic inflammatory
myopathies showed a positive response to physical training in the absence of an
adverse inflammatory reaction (Alexanderson, Stenstrom & Lundberg, 1999;
Wiesinger, et al., 1998A; Wiesinger, et al., 1998B). Furthermore, studies with IBM
patients using strength training and aerobic exercise as part of the patient's treatment
concluded that exercise can be performed by the IBM patient safely and can lead to
dynamic strength improvements and possibly prevent loss of muscle strength
(i\rnadottir, et al., 2002; Spector, et al., 1997).

Optimal exercise guidelines resulting in improvements in muscle strength and
function have not been established in either a home-based or laboratory setting. The
emphasis this study placed on the improvement of patient function by having the
patients perform exercises specifically designed to improve function, including the
use of multi-joint exercises and the integration ofbalance and stabilizing components
to the exercises, distinguishes this study from previous exercise intervention studies in
this clinical population. The training program in this investigation was also quite
novel in that it included the training of both diseased and non-diseased muscles, and
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uses within-subjects and within-study controls to assess the impact strength training
had on these various muscle groups.

From subjective interviews with the patients, it was noted that previously these
patients received physical therapy that was too strenuous and resulted in exacerbated
muscle pain and further muscular weakness. However, this study has shown that
carefully considered exercise load prescription can result in the attainment of
functional benefits and strength gains.

The conservative approach this study has

taken supports a study by Kilmer, Wright and Aitkens (2005).

A pilot study

undertaken prior to the commencement of the present study identified program
adherence and excessive muscle fatigue/soreness leading to possible non-compliance
and/or withdrawal from the study as potential challenges this study would encounter.

The pilot study performed on a group of IBM patients (including a number of
patients in this study) provided an insight into the compliance of the patients to
perform their exercise program at home when not under the direct supervision of the
investigator to be a limiting factor in strength and functional improvements. In the
present study, compliance was defined as adhering to the program and undertaking
the exercises as prescribed for greater than 70% of the intervention period.

The

diaries given to the patients to record their daily activities in, and the regular
patient/investigator contact via the telephone, was expected to minimise the degree of
non-compliance and to provide the impetus for the patient to maintain a detailed
record of what they were actually performing in their exercise sessions. Positive
reinforcement from the investigator and the patients' partners and the maintenance of
the patients' scheduled visits to the Neuromuscular clinic are other measures that were
put in place to ensure program adherence.

However, upon post-intervention

interviews, two of the group were assessed as being non-compliant, having not
completed the majority of the exercise program as instructed. For various reasons,
both subjects exercised infrequently and applied a training load not specified by the
investigator. As a result of this, the results of this study have at times been analysed
as two separate entities; a compliant group and a non-compliant group.

The selective pattern of muscle involvement that characterises IBM patients
ensured that the exercise program had varying effects on the muscle groups tested in
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this study.

The significant increases in muscle strength observed in four of the

trained/healthy muscles tested indicates the importance of strength training in this
patient group, as whilst these muscle are not directly involved in the disease, they play
important roles in the patients capacity to perform daily, functional activities. The
maintenance of strength through training of an involved muscle is another important
finding. When analysed in light of the mild strength loss in the untrained/diseased
muscle (grip strength), this clearly suggests 'Strength training can delay the loss of
muscle strength in muscles typically involved in IBM, thus supporting findings
reported by Spector et al (1997).

The progressive nature of IBM results in the gradual deterioration of strength
m the muscles selectively involved in this disease.

This must be taken into

consideration when analysing the effect of a strength training exercise program on the
diseased muscle groups. A definitive rate of decline in strength is unknown in this
pathological group; however, a study by Rose, McDermott, Thornton, Palenski,
Martens and Griggs (2001) found a mean decline in muscle strength of 4% from
baseline in IBM patients over a six month period. Lindberg, Persson, Bjorkander and
Oldfors (1994) reported a 1.4% loss of strength from baseline per month. The loss of
strength in IBM patients' is likely to vary between individuals and the stage of disease
progression they are at (Dawes, Korpershoek, Freebody, Elsworth, van Tintelen,
Wade, Izadi & Jones, 2006). It can be seen from Figure 1 that untrained/diseased
muscle groups can experience a noticeable decrement in strength over a 12-week
period.

The variability in the degree of weakness and level of endurance between
different IBM patients, and their general level of fitness makes it necessary to design
exercise programs that are specific to each patient. The patient-specific aspect of this
study allowed the investigator to overload each patient in consideration of the
progression of the disease and the muscle selectivity that characterises IBM. It also
enables the investigator to integrate the exercise program into the patients' homes
with greater ease by allowing for greater flexibility in the prescription of exercises in
consideration of the availability of space and resources that are present in each
patient's home.
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The involvement of the wrist and finger flexors in this muscle disease affects
the force output of the patients hand and wrist, causing them to have reduced grip
strength. At the completion of the exercise intervention, the compliant patients in this
study exhibited an average decline in muscle strength of 19.6%. This is despite the
fact that the wrist and finger flexors were involved in the performance of other
exercises prescribed to the patients, such as bicep curls. For the entire patient group,
grip strength decreased on average by almost 8% (Table 3 -refer to Appendix N).
The importance of grip strength in the performance of everyday activities should not
be understated, it is required in simple, menial tasks such as hanging out the washing,
drying dishes and serving food, thus the implications of having a reduced grip
strength, that is declining continuously, are serious and a limiting factor in the
patient's ability to independently function.

The decline in grip strength should be kept in mind when examining the effect
of the exercise program on other muscles primarily involved in this disease, but which
were trained in this study. Grip strength can be viewed as a within-subject control for
diseased/trained or untrained muscles, thus the maintenance of strength as shown by
the knee extensors of the compliant patients is particularly promising. The knee
extensors have been shown to maintain their strength over the intervention period and
knee extensor exercises were a major part of the exercise program. The prominent
atrophy and weakness of the quadriceps muscles indicates the extent of damage this
muscle group experiences as a result of the disease (Amato, Gronseth, Jackson,
Wolfe, Katz, Bryan & Barohn, 1996; Arnardottir, Alexanderson, Lundberg & Borg,
2002; Felice, Relva & Conway, 1998) (refer to Appendix L for pictures of a patient in
this study).
The serious consequences this has, as being a core reason as to why this
patient group experiences falls frequently, validates the place of knee extension
exercises in any exercise program to be prescribed in this patient group. Using sit-tostand exercises, which have important functional applications, to improve the patients
muscle· strength in the knee extensors, the compliant patients averaged a 0.9%
improvement in strength. Whilst only a small improvement, this supports findings by
Spector et al (1997), who found muscle groups with the lowest Medical Research
Council (MRC) ratings· pre-training showed the least amount of improvement post43

training.

However, Table 3 shows the average knee extensor strength pre-training to be
7.32 Kg-f, whilst post-training, the patients averaged 6.66 Kg-f of the total patient
group. This is a 10% loss in strength over the 12-week intervention period. This is
obviously offset by the inclusion of non-compliant patients in the data used to
calculate these figures, which further emphasizes the importance of the exercise
program, and the potential benefits that can be derived, by the patients by exercising
the diseased muscle groups. The maintenance of strength in the knee extensors has
implications in the patients capacity to perform functional tasks such as a 30m walk
and a stair climb, with knee extensor strength a key factor in the ability of the patients
to perform these functional tasks, and in particular the ability to climb stairs.

Shoulder external rotation, a healthy/untrained muscle group, was used as a
'control' in this study to establish strong evidence that supports the effect of the
strength training on healthy/trained muscles.

It forms a within-subject control

variable to show that by not adhering to the exercise program, there will effectively be
no net change in muscle strength of an untrained/healthy muscle at the completion of
the intervention period. The collected data of the compliant patients shows they
increased their strength in this muscle by 4.2%, whilst the patient group as a whole,
increased in strength by just over 2% (7.45 Kg-fpre-training compared to 7.64 Kg-f
post-training) (refer to Table 3). The slight increase in strength may be a secondary
effect of the patients exercising the shoulder muscles involved in shoulder external
rotation in the performance of other exercises directed at improving other muscle
actions, such as shoulder abduction. Greater movement at the shoulder joint would
also be expected to have resulted from the patient having undertaken shoulder
strengthening exercises and upper limb stretching movements to enable a more
flexible movement pattern, thus potentially encouraging a greater force production.

Figure 1 shows the statistically significant improvements in shoulder
abduction as a result of the strength training program the IBM patients performed. As
expected, the healthy/trained muscles that perform the shoulder abduction muscle
action responded well to the training, with the compliant patients shoulder abduction
strength improving by ·over 66%. The improvements seen here support previous
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evidence of the benefits that can be derived by using an isometric contraction to target
a particular area (Skelton & Dinan, 1999). The gain in muscle strength achieved in
the shoulder abductors has important applications in the performance of activities of
daily living. Daily chores such as hanging out the washing to dry and washing the
dishes, require upper limb muscle strength, and the inability to perform these tasks
due to a lack of strength reduces the independency of these patients, which negatively
impacts on the patient's ability to care for themselves.

Thus, the importance of

strengthening a non-diseased muscle cannot be understated, for its valuable
contribution to undertaking the most basic, functional tasks should be recognized.

The statistically significant improvement in hip abduction strength in a
healthy/trained muscle in this study has important implications for the daily
functioning and general health and well:.being of this patient group. A 59% increase
in hip abduction strength was found in the compliant patient group, whilst statistical
significance was also found when comparing pre and post muscle strength scores of
the total patient group (Table 3). Hip abduction strength has practical applications as
a key factor in balance and stabilizing tasks. The lower limbs abduction muscles are
vital during walking to maintain the body's weight over the limb that is in contact
with the ground. Hip abduction strength is also a necessary tool for stabilizing tasks,
which is particularly useful in this patient group that is prone to falls. Developing
strength in this area is advantageous to the patient as a balance strategy to resist
falling or correcting displacement.

Postural control and improved gait are other

functional benefits derived from a lower limb strength training exercise program
(Campbell, Robertson, Gardner, Norton, Tilyard & Buchner, 1997; Simpson,
Harrington & Marsh, 1998).

In addition to hip abduction strength, hip flexor strength is another vital
component of an exercise program that aims to primarily improve the functional
capacity of this patient group by improving the patients muscular strength, endurance
and function. Hip flexor strengthening has been shown to play an important role in
developing greater postural control and improving the gait of the elderly, and in
particular those that are more susceptible to falls, which is prominent in IBM patients
due to their weakened quadriceps (Campbell, et al., 1997; Simpson, Harrington &
Marsh, 1998; Skeltoti & Dinan, 1999). IBM patients tend to develop abnormal gait
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patterns due to lower limb wealmess, resulting in either increased risk of falling, or
reduced mobility as a consequence of a fear of falling (Lord, Lloyd & Li, 1996). By
improving hip flexor strength, it is anticipated the patients will be less susceptible to
falls and experience improved dynamic stability when trained in combination with
other lower limbs, which will have a follow-on effect on the patients' confidence to
be more mobile, which in tum has numerous secondary health benefits for the patients
(Kannus, Sievanen, Palvanen, Jarvinen & Parkkari, 2005; Lord, Ward & Williams,
1996).

In the compliant subset of patients, hip flexor strength significantly improved

by over 83% over the 12-week intervention period, and statistical significance was
also attained when analysing the strength gains of the entire patient group, as shown
in Table 3. Muscle strength improvements in healthy muscles as a result of exercise
training are to be expected, and the results of the present study provides ample
evidence of the benefits that can be gained from a patient specific, functional exercise
program. The highly favourable response to training is likely to be due to the lowlevel of pre-training fitness, as the majority of this patient group have been sedentary
for a number of years, due to the reduced mobility and the fatigue they experience
when they are active (Spector, et al., 1997).

Figure 2 presents the overall mean change in muscle strength of both the
compliant and non-compliant patient groups at the completion of the exercise
program. The compliant patients experienced over a 38% increase in muscle strength
for all muscles trained, which was significantly different to the average change in
muscle strength experienced by the non-compliant patients. This figure emphasizes
the importance of undertaking the exercises as prescribed and instructed, and supports
the hypothesis that an exercise training program can result in muscle strength
improvements in this patient group.

The findings in this study support work by

Spector et al. (1997) who found significant strength changes following a short-term
exercise program in ffiM patients.

Almost all healthy muscles (trained or untrained) showed an increase in
strength post-training (Table 1). One exception to this is elbow extension, which on
average experienced a loss of strength over the study. The elbow extensors were
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'trained' in as much as they were involved in the sit-to-stands all patients were
required to undertake. Each patient was asked to use their upper limbs to lower
themselves back into a seated position after each repetition for each sit-to-stand set
performed by the patient. The limitation of this is that the effort and concentration
required by the patients to perform the sit-to-stands may have potentially resulted in
the patients not following the instructions of using their arms to lower themselves
back into a sitting position.

However, this study was initially designed to exercise the patients usmg,
where possible, functional and multi-joint exercises to make the program time and
energy efficient but also with transfer into activities of daily living. The muscular
fatigue experienced by this patient group, limits the amount of time and the intensity
of effort the patients can apply to their program, so an exercise plan that has the
patient training numerous muscles through a small number of exercises will not only
be well tolerated by the patients, but encourage compliance as opposed to longer
exercise sessiOns.

In analysing the results, and using information provided by the patients in both

subjective interviews and diary recordings, it is possible to present some interesting
figures through a case study.

Figures 3a and 3b are a comparison between two

patients, with Figure 3a a pre-post comparison of the mean muscle strength data for a
single, compliant patient, whilst 3b presents the same values, but for a single, noncompliant patient. The compliant patient recorded a statistically significant difference
between pre mean muscle strength score for all trained muscles. This patient was
highly compliant, undertaking the exercise program as instructed, and was assisted
through positive reinforcement and constant and strict supervision by their partner.
The patient's diaries were very detailed and both the patient and their partner strongly
expressed the view that very few, if any, exercise sessions were not completed. The
patient's mean strength improved from 5.9±0.6 Kg-f pre-training, to 7.3±0.8 Kg-f
post-training.

This is in contrast to the non-compliant patient, who not only missed exercise
sessions, but also failed to perform the exercises in each session as instructed. This
patient failed to record any exercise information, which makes it difficult to quantify
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how much exercise the patient performed, despite the encouragement and close
monitoring provided by the investigator. However, in interviews with the patient, it
was clear that they had performed very little of the exercise programme, and thus
were assessed as being non-compliant in this study. The patient averaged 13.2±1.3
Kg-fin muscle strength pre-training, but experienced a non-significant loss in strength
over the 12-week intervention period and recorded a mean value of 12.7±1.2 Kg-f
post-training.

In comparing the muscle strength results of these two patients, they provide
further evidence of not only the capacity of the exercise program to enable the
patients to attain muscle strength improvements due to a patient-specific, functional
exercise plan, but also the importance of adhering to the exercise program. Figure 3b
shows non-compliance can potentially result in a loss of muscle strength which this
individual patient experienced, which supports the findings presented earlier in Figure
1 detailing the loss of muscle strength in grip strength in the absence oftraining.

The change in functional capacities of the compliant patients in this study,
whilst not statistically significant, should not be understated. As can be observed
from Table 2, in all three functional tests, the compliant patients improved following
the training intervention. The time taken to climb one flight of stairs was reduced
from an average of 19.4±10.7 seconds pre-training to 15.2±6.1 seconds post-training.
The 30 metre walk time also decreased following the training intervention, from
43.4±20.4 seconds to 29.8±8.8 seconds. The reduced walk time was accompanied by
a reduction in the number of paces used by the patient to perform the walk, with the
compliant patients averaging 67.0±20.0 steps pre-training and 52.8±7.2 steps posttraining. This reduction in number of paces used to perform the walk is indicative of
the patients developing a larger amplitude gait.

In the absence of statistical significance, a clinical perspective can be applied
to the functional improvements seen in this study, whereby for various reasons, such
as small subject numbers and the insensitivity of the tests in detecting change (Rider,
1996), the patients did not achieve statistical significance, the improvements seen may
be viewed as an example of clinically significant results. Additionally, the progressive
nature of. the disease, which has been shown to cause the patients to lose muscle
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strength, may have had a limiting effect on the improvements in functional capacity
over the 12-week intervention period. However, mild improvements, as seen in this
study group, have important functional implications in the patients' activities of daily
living. The ability to walk faster over a set distance means less energy is expended
and the patient can therefore walk further in the absence of fatigue. This enables the
patient to be more independent, such that they can go to the shops with their partner;
they can spend an afternoon in a park without becoming over-fatigued from any
walking they may have to undertake.

The ability to walk further and faster may also result in the patient delaying
the need to use a wheel chair or motorised buggy to locomotor. The immobility that
accompanies these movement aids has serious implications for future health issues, in
particular cardiovascular disease and other secondary co-morbidities, as a
consequence of the sedentary lifestyle the patient is forced to live (American College
of Sports Medicine, 2000, p.5). Being able to walk more and climb stairs with greater
ease can simply mean the patient is able to move around their house without the
assistance of their partner or carer, and activities of daily living can be performed with
greater ease and confidence by the patient. This would potentially have positive
psychological benefits for the patients, who are able to feel more independent and
confident in their ability to perform tasks on their own and contribute to the
community, and less dependent on their partner, carer or others to assist them.

Using the same two patients that were identified in Figure's 3a and b, Figures
4 and 5 provide a contrasting observation of the difference in functional capacity
changes over the 12-week intervention period by a compliant and non-compliant
patient.

Figure 4 further highlights the importance of adhering to the exercise

program and the benefits of the patient-specific program itself, as this figure shows
the functional improvements that can be made by an individual, compliant patient
over a 12-week period. The patient reduced their stair climb time by 25 seconds, a
64% improvement in time taken to perform the task, whilst their 30 metre walk time
was reduced from 125 seconds pre-training to 64 seconds post-training, an
improvement by over 95%. This descriptive data clearly shows the influence the
exercise program had on this patient and their capacity to perform simple functional
task such as a stair. climb. and 30 metre walk.
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Figure 5 presents data from the same functional tests, but shows the reduction
in functional capacity resulting from non-compliance to the exercise program. In the
patient's post-training functional assessment, their time taken to walk 30 meters and
perform the stair climb increased from their pre-training levels. In the case of the stair
climb, the patient's time increased by 13%, from 19 seconds pre-intervention to 22
seconds post-intervention. Their 30 metre walk time went from 31 seconds pretraining to 50 seconds at the completion of the exercise intervention, an increase in
time by over 61%. This data adds further weight to the evidence this study provides
in support of the importance of an exercise program for this patient group in the
prevention or delaying of a loss of muscle strength and functional capacities.

The careful and selective prescription of exercise load was primarily based
upon exercise rehabilitation guidelines for other pathological groups. According to the
American College of Sports Medicine (2000, p.145) guidelines, for optimal strength
and functional gains to be attained, the patient should adhere to an exercise program
that emphasises higher frequencies and longer duration exercise sessions at lower
intensities. This was adhered to by the investigator when prescribing each patient's
exercise program. In establishing the patients' exercise programs, the investigator
deliberately avoided emphasising eccentric muscle contractions for the damaging
effect on muscles they have been shown to cause (Jones, Newham, Round & Tolfree,
1986). Rather, multi-joint exercises, isometric and concentric muscular contractions
were preferentially prescribed along with movements and functional positions that
emphasised balance and stability within the training program.

Class-based versus home-based exercise rehabilitation therapy has been
investigated in a variety of pathological groups (Ashworth, Chad, Harrison, Reeder &
Marshal, 2005), and the cost-effectiveness, compliance rates, and overall results from
both strategies have merit (Carmelli, Sheklow, & Coleman, 2006).

Home-based

programs are easy to implement (Ashworth, et al., 2005), accessible to the patient
(Lim, Moon & Lee, 2005), and encourage compliance (McCarthy, Mills, Pullen,
Richardson, Hawkins, Roberts, Silman & Oldham, 2004). The impaired mobility that
typifies an IBM patient gives a home-based exercise program advantages over a classbased program. Such advantages include the safety and familiarlarity of exercising in
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the familiar surroundings of their own home, the assistance and encouragement of
partners, the flexibility to perform the exercises according to their own schedule, and
the avoidance ofhaving to arrange suitable transport.

Despite being an integral component of this study, the home-based setting
with which the exercise program was designed for and performed in presented the
investigator with a number of challenges. Program monitoring is comprehensively
more challenging in this home-based study compared to a laboratory or clinic setting
whereby constant observation and supervision can be applied. Ensuring the patients
perform the exercises, use the correct techniques and apply the appropriate training
load are just a number of the issues that confront the investigator when establishing a
home-based therapeutic intervention.

Controlling external factors, such as other

activities and chores the patient undertakes which may impact on the patients fatigue
and muscle weakness levels whilst partaking in the exercise program, is also an issue
that requires further examination. Verbal instructions with regards to the importance
of recovering between exercise sessions and limiting the amount of strenuous
activities performed during the study period was impressed upon the patients.

However, it is both unethical and unfeasible to ask the patient to abstain from
any activities that may make them tired or weak on the premise that this will
negatively impact on their capacity to consistently perform their exercise program.
Future studies need to consider this point, and it is recommended that a specific rating
system of energy exertion during the undertaking of regular, daily activities could be
useful in attempting to quantify the fatigue levels being experienced by the patients
when performing these activities of daily living. This would enable the investigator to
closely monitor the patients' energy and fatigue levels, and then prescribe exercise
accordingly.

In order to establish if exercise should be prescribed as part of the

routine clinical management of IBM patients', it was felt that it should be determined
if exercise training in the patients' home is practically achievable and therefore we
considered that the nature ofhome-based exercise was integral to this study.

In evaluating the completed diaries of the patients, there was much variability
in the amount of the exercise program performed by each patient. Two of the patient
group did_not attempt to. fill out a diary, so it is difficult to make a formal conclusion
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on the adherence to the program by the patient's, other than what was verbally
communicated to the investigator by each patient in subjective interviews at the
completion of the exercise program. For reasons such as an illness, having friends
staying with them, or having to go away from home, five of the patient's felt that they
missed a small percentage of days within the intervention period, but never for more
than 5-6 days at a time, and this is supported by diary entries by this subset of
patients. The non-compliance of two of the patient's in the study group was the
reason why the investigator took the approach of analysing the results in two separate
data sets.

Despite ngorous efforts to encourage and monitor patient compliance,
ensuring the patients adhered to the exercise program and performed the training as
prescribed was challenging.

Physicians should therefore consider this when

prescribing exercise to this clinical population. The program was developed to ideally
exist in the absence of daily interactions with the investigator and the associated
constant supervision, as it was the intention of the investigator to develop the program
in such a way so as to make the exercise program a behavioural change and an
addition to the patients' everyday lifestyle, not something the patients were forced to
do and travel to and from a gym or clinic to undertake.

Despite encouraging self assessments from each patient with regards to their
adherence to the exercise program throughout the intervention period, it is difficult to
make any formal conclusion of overall compliance to the program with the variability
that existed between each patient in their diary entries and without the factual
information of how often the patient actually performed the exercises that the diary
was intended to provide. In consideration of the non-compliance by two patients in
this study, some viable recommendations could go some way to ensuring future
similar studies are not hindered by the issue of non-compliance, or at least the lack of
indisputable facts needed to make sufficiently justified statements of the training load
each patient performed. A more interactive method of program monitoring could
provide' the necessary stimulus required to ensure the patients are not only
undertaking their exercises, but also to further encourage them to maintain their
exercise diaries, regardless of what they did or did not do. More regular contact via
phone calls and possibly, more home-visits by the investigator are two realistic means
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of increasing the investigator/patient contact.

A more direct involvement by each patient's personal support network could
also lead to improvements in patient self-assessment and exercise recording. This
could involve simply having the patients' wife/husband/child listening in on all
meetings between the investigator and patient and being involved in the
implementation of the exercise program into the patients home.

Obviously, the

patient is given the opportunity to involve who they wish and invite them along to any
and all meetings between themselves and the investigator, but additional
encouragement to do this by the investigator could ensure every patient has the
necessary support to undertake the exercise program. Taking this a step further, it
would be quite possible to involve the patient's partner in the actual exercise program
and make the exercise therapy a joint interest the patient and their partner could share
with potential positive benefits for both. Having someone in the patients home to act
as 'interactive supervisors' in the absence of the investigator to ensure the exercises
are correctly undertaken and recorded, provide encouragement and positive
reinforcement and to ensure the safety of the patient is an important facet of homebased exercise programs if they are to be successful.

Another option that may potentially have a positive effect on the compliance
of the patients to the program and also stimulate them more to record their progress is
the establishment of a once-weekly group exercise session delivered in a gym-type
setting. Balance and physical performance has been shown to be improved as a result
of class-based, supervised exercise programs in older adults (Carmelli, Sheklow &
Coleman, 2006; Judge, 2003). This would provide the patients with motivation to do
their exercises in the knowledge that their progress will be more closely followed by
the investigator when they attend these sessions each week. It would also provide the
investigator with the opportunity to deliver more specialised exercise programming
and work more hands on with the patients in a rehabilitative setting. The social aspect
of having a group of patients with the same disease interacting and supporting each
other would likely have a positive influence on the patients and provide further
motivation to attend each week knowing a friend will be there and is facing the same
problems and daily issues as them. This is particularly prevalent in this pathological
group exhibiting a muscle disease that is seemingly quite uncommon.
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Whilst

conflicting evidence surrounds the impact of home-based and class-based exercise
programmes, further research is required to assess why patients are/are not adhering
to exercise programs and diligently recording their performance, regardless of the
setting. This would then provide investigators with the fundamentals necessary to
establish research projects designed to enable investigators to make conclusive
statements on the type of exercise setting that will best induce optimal training effects.

The role CK plays during exercise has been comprehensively examined,
resulting in CK levels being the primary biochemical marker of muscle damage
following a bout of exercise (Clarkson & Tremblay, 1988; Houmard, Costill,
Mitchell, Park, Fink & Bums, 1990; Shahbazpour, Carroll, Riek & Carson, 2004;
Totsuka, Nakaji, Suzuki, Sugawara & Sato, 2002). It is felt that CK is a reliable
measure of muscle damage following , exercise in myopathic patients (Phillips &
Mastaglia, 2000). However, studies on inflammatory myopathy patients have shown
that despite an immediate rise in CK levels following strength training, the rise does
not seem to be sustained for any more than a few hours, and certainly with no longlasting changes in the patients CK levels following exercise have been observed
(Amadottir et al., 2002; Escalante, Miller & Beardmore, 1993; Hicks, Miller, Plotz,
Chen & Gerber, 1993; Spector, et al., 1997). This study did not result in significant
serum CK changes, thus supporting previous findings that exercise can be safely
tolerated by this patient group.

The small number of subjects in this study has implications for the statistical
power of the results and the subsequent conclusions drawn from the data. However,
with the muscle disease being quite rare, the actual numbers which make up this study
are comparative to other exercise therapy studies involving neuromuscular disorders.
The progressive disabling nature of the disease and the symptomatic muscle weakness
and fatigue caused a number of patients to withdraw from the study either prior to it
beginning or during the intervention period. The decision to withdraw was often
made apologetically and whilst most wanted to continue or start the exercise program,
they simply felt that the exercises were not going to help them and it would therefore
be a waste of their time and effort.

The assessment, of muscle strength by a hand-held myometer, which
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employed regularly in clinical settings, provided accurate, valid and reliable results
(Agre, Magness, Hull, Wright, Baxter, Patterson & Stradel, 1987; McMahon, Burdett
& Whitney, 1992), as did the testing of the patient's functional ability. The functional
tests performed by the patients are commonly clinically applied in the testing of a
variety of muscle disorders. The aerobic testing of the patients was quite a novel
procedure for this pathological group, but it was carefully planned and designed to
account for individual differences between the patients and any co-morbidities that
were present.

The testing procedure was thoroughly researched and critically

assessed prior to being used, and was based on a number of similar protocols
established in the testing of other symptom-limited pathologic groups.

The testing procedures used in this study were reliable and valid measures of
both muscle strength and functional capacity and inter-rater reliability was confilmed
for all measures tested. However, the importance of assessing the impact of any
exercise intervention on a clinical population's quality of life (QOL) should be
prioritised and should be a key outcome measure in studies such as this one.
Improvements in muscle strength and endurance are vital, but it is how these changes
advantage the everyday lives of the patients and improve their functionality that is the
key issue.

Currently, further research is required to develop valid, reliable and

sensitive QOL scales for this particular patient group.

The use of the SF-36 as the quality of life instrument to assess general health
and functional changes as a result of the training intervention is based on it's
prevalence in the literature pertaining to similar studies of neuromuscular patient
groups. Despite it not being a muscle disease specific measure, it has been shown to
be a valid and reliable measure of a patient's overall health status (Alexanderson,
Stenstrom & Lundberg, 1999). The SF-36 was trialled in this study, but in reviewing
the patients' pre- and post-intervention questionnaires, the investigator found the
questionnaire lacked specificity when applied to this particular clinical population.
Despite its application in a number of liM studies (Isenberg, et al., 2003; Sultan,
Ioannou, Moss & Isenberg, 2002), the validity of the SF-36 as a QOL measure for
IBM patients needs further clarification.
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6. Conclusion

In IBM patient's, significant strength gains can be attained in non-diseased

muscles, strength can be maintained in the diseased muscles, and functional
improvements can be made in the absence of muscle damage as a result of a homebased, patient-specific, functional exercise program. In normal populations, a muscle
that has experienced atrophy can regain size and strength through resistance training,
however, studies have shown that strength training does not seem to cause muscle
hypertrophy in IBM patient's, or at least it does not do so to a sufficient number of
muscle fibres required to make a significant contribution to result in a change in
muscle size (Phillips & Mastaglia, 2000; Spector, et al., 1997). Other possibilities
which may explain the increase in muscle strength observed in this patient group
following the exercise intervention include a ·change in fibre type (Alexanderson &
Lundberg, 2005; Arnadottir, et al., 2002) and recruitment patterns. An increase in
muscle fibre cross sectional area has been seen in muscle biopsies following an
exercise intervention in IBM patients; however, a significant result was not
established and questions remain as to whether or not muscle undergoes hypertrophy
in response to a strength training program (Arnardottir, et al., 2002).

Motor learning and an improvement in the co-ordination of muscles activated
during the performance of a task may also contribute to strength gains and functional
improvements.

We propose that the present approach has been beneficial to the

patient's by slowing muscle atrophy and improving co-ordination and activation of
muscle groups to perform a given task. Although improvement in the functional tasks
did not reach significance, the use of functional weight-bearing activities in the
exercise program may assist the patient in average daily living activities (Littbrand,
Rosendahl, LindelOf, Lundin-Olsson, Gustafson & Nyberg, 2006; Wilson, Murphy &
Walshe, 1996). It should be considered that the sample size used in this study is
likely to have affected the statistical power of the data analysed. The results are
particularly promising when taking into consideration that the training did not include
an aerobic component that could potentially specifically enhance the patient's ability
to move with greater control, therefore, a reduction in energy expenditure resulting
:from excessively co-contracting muscles.
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Exercise guidelines are substantially lacking for this patient group; however,
exercise has been shown to have a positive effect on an IBM patient's muscle strength
in previous studies (Amardottir, Alexanderson, Lundberg & Borg, 2002; Spector, et
al., 1997). This study provides evidence to support the prescription of a carefully
controlled, patient-specific exercise program. In the absence of disease progression
markers, this study shows that muscle strength and function can be improved by mild
daily exercises performed in the patient's home. Key factors such as adherence,
exercise prescription, the initial training load and the subsequent progression of the
training program must be considered and thoughtfully planned in any future
investigations.

Exact training protocols and the relevance such strength and

functional improvements have on the patients quality of life, requires further
investigation with large sample sizes in controlled, long-term training interventions
using validated, disease-specific quality' of life scales. This would perhaps require a
coordinated multi-centre, randomized controlled, clinical trial. However, this study
has shown that exercise, in particular, strength training, may be an important
component of the routine management and long-term treatment of patients with
Inclusion Body Myositis.
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This mechanism might be the cause of increased myostatin precursor
demonstrated in s-IBM muscle fibers. Increased myostatin precursor/myostatin might contribute to muscle-fiber atrophy and other changes in
s-IBM.
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Granulysin expression in polymyositis and inclusion body myositis
Koji Ikezoe*, Sachiko Oshima, Manabu Osoegawa, Masato Tanaka,
Kazuyuki Ogawa, Kinya Nagata, Jun-ichi Kira
Japan
Background: Granulysin, a recently defined cytolytic molecule, is
expressed in cytotoxic T and natural killer cells; similar to perforin,
which is reported to play a major role in the pathogenesis of
polymyositis (PM) and inclusion body myositis (IBM). Objective: To
clarify the role of granulysin in PM and IBM. Methods: We examined
the expression of granulysin and perforin by double-staining with CDS,
CD4, and CD56 in endomysia! infiltrating cells and autoinvasive cells in
17 muscle biopsies of PM (6 steroid resistant, and 11 steroid responsive),
and 7 IBM. Results: Similar to perforin, granulysin was expressed in
CDS+, CD4+, or CD56+_cells in PM and IBM. However, only the
ratio of cells double positive for granulysin and CDS to all CDS+ cells
at endomysia! sites was significantly higher in steroid resistant PM than
in steroid responsive PM and IBM. Conclusion: Granulysin expression in'
CDS+ cells appears correlated with steroid resistance in PM.
M-P-6.05
A pilot study on the effects of a patient-specific, home based, functional
exercise program on patients with Inclusion Body Myositis (IBM)
Liam Johnson*, Dylan Edwards, Gary Thickbroom•, Frank Mastaglia•
Centre for Neuromuscular Disorders, The University of Western Australia;
School of Exercise, Biomedical and Health Sciences, Edith Cowan
University; aCentre for Neuromuscular Disorders, The University of
Western Australia
Previous research has shown exercise to be beneficial in the treatment
of myositis-affected patients. The potential of functional exercises to
improve muscle strength and function in the absence of disease
progression markers is not well understood. We believe that an exercise
program tailored to the patient is important for routine management and
long-term treatment. The present study investigated the effects of a
home-based, patient-centered functional exercise program, on muscle
strength and patient mobility. Patients were tested pre and post, a 16
week, patient-specific, home exercise program involving mild, daily
functional exercise. Outcome measures included a hand-held dynamometer for muscle strength, whilst a 30 m walk and stair climb was
performed to ascertain changes in overall functional ability. Inter-tester
-reliability was confirmed for the measures used. Creatine Kinase (CK)
was monitored over the intervention period. Strength improved for all
muscles tested, with results as follows; shoulder abduction 39.4±
IOSEM%, shoulder external rotation 7±1S, elbow extension 39.2±S,
elbow flexion 57.7 ± 14, wrist extension 50.7 ±21, hip flexion 169.S±56,
hip abduction 56.1 ±20, knee extension 36.1 ± 10 and knee flexion
62.0±24. There was a post-intervention improvement in average time
taken to climb one flight of stairs (13.S±3 s reduced to 11.5±3 s) and
walking unaided for 30 meters (41 ±5 s reduced to 34±6 s). The number
of paces to perform the 30m walk was also reduced (5S.S±3 to 54.S±
4). Serum creatine kinase levels remained constant throughout the
intervention period. Results from this preliminary study show that muscle
strength and function can be improved by mild daily exercises performed
in the patient's home. In the absence of disease progression markers, our
individually prescribed home exercise program over 16 weeks has shown
that simple functional exercise activities can be beneficial in the clinical
management of myositis patients.
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CONGENITAL MYOPATHlliS; POSTER PRESENTATIONS
M-P-15.01
A comparative morphological study of heart and skeletal muscle in
mutation-proven desminopathie
Hans H. Goebel*, Rolf Schroeder", Walter Schulz-Schaefferb,
Lev Goldfarbc
Department of Neuropathology, Johannes Gutenberg University Medical
Center, Mainz, Germany; a center for Biochemistry, University of Cologne,
Germany; bDepartment of Neurology, Georg-August University, Goettingen, Gennany; " National Institute of Neurological Disorders and Stroke,
National Institutes of Health, Bethesda, Maryland, USA
Background: Desminopathies are molecularly marked by mutations in
the desmin gene, clinically by musle weakness, often of late onset and more
distal than proximal, and frequently cardiac disease, morphologically of
degeneration of sarcomeres and aggregation of desmin and many other
proteins appearing as inclusions or wide spread granulofilamentous
material within muscle fibers. Purpose: To assess the morphology of
cardiac pathology and compare it with myopathology in skletal muscle
fibers in mutational desminopathy. Material: Cardiac tissue obtained by
biopsy or explantation for heart transplantation of three genetically affected
patients. Methods: Histology, immunohistochemistry, electronmicroscopy.
Results: Myocytes in both skeletal muscle and heart gave identical
disruption of sarcomeres and accumulation of granulofilamentous material
often amassed at the intercalated discs of cardiomyocytes and beneath the
sarcolemma in skeletal muscle fibers. Conclusion: As desmin is the
intermediate filament of both skeletal muscle fibers and cardiomyocytes
encoded by the same gene with, hence, mutations in the DES gene affecting
both organs the similar pathomorphology underscores such genotypemorphotype correlation and forms the basis for clinical involvement of
skeletal muscle and heart.
M-P-15.02
Severe nemaline myopathy caused by mutations of the stop codon of the
skeletal muscle alpha actin gene (ACTA1)
William Wallefeld*, Sabine Krause•, Kristen Nowak· Rita Horvath•, Zoltan
Molnarb, Miklos Szabob, Ichizo Nishinoc, Hanns Lochmiiller•, Nigel Laing
Molecular Neurogenetics Laboratory, Centre for Medical Research,
University of Western Australia, Western Australian Institute for Medical
Research, B Block, Queen Elizabeth II Medical Centre, Nedlands, Western
Australia; aMolecular Myology Lab, Friedrich-Baur-Institute, Department
of Neurology, Ludwig-Maximilians-University of Munich, Marchioninistr.
17, 81377 Milnchen, Germany; bFirst Department of Pediatrics,
Semmelweis University, Bakay u. 53, 1083 Budapest, Hungary; <Department of Neuromuscular Research, National Institute of Neuroscience,
National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8502, Japan
P.urpose: Most nemaline myopathy patients have mutations in the
nebulin (NEB), or alpha-skeletal actin (ACTA!) genes. We have
performed screening of the ACTA! gene in multiple patients with
congenital myopathies from Europe and Japan. Here we report for the
first time mutations of the ACTA! stop codon in two patients, one from
Hungary and one from Japan, with severe nemaline myopathy with
dystrophic changes on muscle biopsy. Methods: All six coding exons of
the alpha-skeletal actin gene were sequenced from genomic DNA using
our previously published methods. Western blotting was performed using
an antibody to sarcomeric actins. One of the stop codon mutations was
cloned into pEGFP-Nl (Clontech) and expressed in C2C12 cells
according to our previously published protocols. Results: A heterozygous
TAG>CAG (glutamine) mutation of the ACTA! stop codon was
identified in the patient from Hungary and a heterozygous TAG>TAT
(tyrosine) mutation in the Japanese patient. Both mutations will cause
inclusion of an additional 47 amino acids, translated from the 31UTR of
the gene, into the mature actin protein. Western blotting performed on

AppendixB
Diagnostic criteria for the diagnosis of
sporadic-IBM

Table 3.2. Diagnostic criteria for s-IBM
Characteristic features
A. Clinical
1. Duration of illness: more than 6 months
2. Age of onset: more than 30 years old
3. Muscle weakness must affect the proxinuil and distal muscles of
arms and legs, and
.
the patient must exhibit at least one of the following features:
(a:) Finger-flexor weakness
(b) Wrist-flexor weakness greater than wrist-extensor weakness
(c) Quadriceps-muscle weakness (grade 4 MRC)
B. Laboratory
1. Serum creatine kinase less than 12 times normal ·
2. Muscle biopsy
(a) Inflammatory myopathy characterized by mononuclear-cell in
vasion of non-necrotic muscle fibers ·
(b) Vacuolated muscle fibers
\,\
OOEth~
,,
(i) Intracellular amyloid deposits (must use fl.uoresce·nce
method of identification before excluding the presence of
amyloid) or
(ii) 15-18-nm tubulofi.laments shown by electron microscopy
3. Electromyography findings must be consistent with the features of
an inflammatory myopathy (i.e., irritable myopathy); long-duration
potentials are commonly observed and do not
exclude a diagnosis of s-IBM
c; Family history
Rarely. s-IBM can be observed in families. This condition is
different from h-IBM without inflanunation. Familial cases of s-IBM
require documentation of the inflammatory component by
muscle biopsy, in addition to vacuolated muscle fibers, intracellular
(within muscle fibers) amyloid, and 15-18-nm tubulofilaments.
D. Associated disorders
IBM can occur with a variety of other disorders, especially immunemediated conditions. The presence of an associated condition does not
preclude a diagnosis of s-IBM if the following diagnostic criteria are
met.
II. Diagnostic criteria for s-mM
A. Definite s-IBM
Patients must exhibit all muscle biopsy features, including invasion of
non-necrotic fibers by
mononuclear cells, vacuolated muscle fibers, and intracellular (within
muscle fibers) amyloid deposits or 15-18-nm tubulofllaments. None of
the other clinical or laboratory features are mandatory if the muscle
biopsy features are diagnostic.
B. Possible s-IBM
If the muscle shows only inflammation (invasion of non-necrotic muscle
fibers by mononuclear cells) without other muscle biopsy features of
IBM, then a diagnosis of "possible s-IBM" can be made if the patient
. exhibits the characteristic clinical (I.A.1,2,3) and laboratory (I.B.1,3)
features. Neither I.C nor I.D should exclude a diagnosis of s-IBM. ·

I.

Griggs, R.C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J.R., &
Rowland, L.P. (1995). Inclusion body myositis and myopathies. Annals of

Neurology, 38(5), pp.705-713;

Appendix C
Patient consent form signed by each
patient that took part in the study

CONSENT FORM
The Effectiveness of a Home-Based, Patient-Specific, Functional
Exercise Program on Patients with Inclusion Body Myositis (IBM)

Investigators: Professor Frank Mastaglia, Dr G Thickbroom, Dr Merrilee
Needham, Dr Dylan Edwards and Liam Johnson
Subject Name: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Date of Birth: _ _ _ _ _ __

1. I have been given clear information (verbal and written) about this study
and have been given time to consider whether I want to take part.
2. I have been told about the possible advantages and risks of taking part in
the study and I understand what I am being asked to do.
3. I have been able to have a member of my family or a friend with me while I
was told about the study. I have been able to ask questions and all
questions have been answered satisfactorily.
4. I know that I do not have to take part in the study and that I can withdraw
at any time during the study without affecting my future medical care. My
participation in the study does not affect any right to compensation, which I
may have under statute or common law.
5. I agree to take part in this research study and for the data obtained to be
published provided my name or other identifying information is not used.
If you are unclear about anything you have read in the Patient
Information Sheet or this Consent Form, please speak to your doctor
before signing this Consent Form.

Name of Patient
Date

Signature of Patient

Name of Investigator
Date

Signature of Investigator

The Sir Charles Gairdner Hospital Human Research Ethics Committee has
given ethics approval for the conduct of this project. If you have any ethical
concerns regarding the study you can contact the secretary of the Sir Charles
Gairdner Hospital Human Research Ethics Committee on telephone No. (08)
. 9346.3528.

AppendixD
Muscle Assessment form used by
investigator to record the patients
muscle strength results

I
I

MUSCLE ASSESSMENT
NAME: _ _ _ _ _ _ _ _ _ _ _ _ CUNlC NO: _ _ DATE: _ __
fSOMETR fC TESTING

Shoulder

Left

R i__g_ h t

MRC

MRC

abductors

Shoulder ex l. rotators
Elbow extensors
Elbow flexors
Wrist extensors
Hip flexors
Hip abductors
Neck flexors
Grip strength
Knee ex tensors
Knee flexors
-----·~•

Ankle dorsif!exors

n

>~-

--------

I

TIMED TESTS
I Stairs

2 Walking

30m/10m

No. Paces

3 Timed Stands
FUNCTIONAL TESTS
I Sit

U[1

rrom lying

2 Rise from squat

Yes/No
Ycs/~t)

Weight
Med iotior1:--

-~-

..

--

AppendixE
Muscle strength assessment positions
for hand-held myometry

..,._

N

---

-----~

Head raised to 30 deg with chin tucked in

Centre of forehead

Nil

Centre of dorsum of foot

Hip abducted 10 deg, knee extended,
foot plantigrade

Ankle dorsiflexors

I Neck flexors

Subject holding side of plinth,
other leg stabilised by
exarruner
Immediately proximal to lateral femoral
condyle

Hip abducted 20 deg, knee extended

Hip abductors

Nil

Nil

Immediately proximal to upper border of
patella

Forearm stabilised on plinth
by examiner

Nil

Hip and knee flexed 90 deg,
lower leg supported by examiner

Immediately proximal to proximal wrist
crease

Shoulder abducted 10 deg, elbow flexed 90
deg, forearm supinated

Elbow flexors

Nil

Hip flexors

Immediately proximal to ulnar styloid
process

Shoulder abducted 10 deg, elbow flexed 90
deg, upper arm in contact with plinth during
test, forearm supinated

Elbow extensors

Nil

Centre of dorsum of hand

Immediately proximal to ulnar styloid
process

Arm at side, elbow flexed 90 deg,
fo~earm mid-prone

Shoulder external
rotators

Nil

Shoulder abducted 10 deg, elbow extended,
forearm pronated and in contact with plinth,
wrist extended 20 deg, fingers flexed

Immediately proximal to lateral epicondyle

Shoulder abducted 20 deg, elbow flexed 90 deg

Shoulder abductors

STABILISATION

Wrist extensors

MYOMETER POSIDON

POSITION OF LIMB SEGMENT

MUSCLE GROUP

TABLE 2.2 -POSITIONS FOR HAND-HELD MYOMETRY

Appendix F
Penny and Giles Transducer Muscle
Myometer used to assess the patients
muscle strength in selective muscles
bilaterally

Penny and Giles Transducer hand-held myometer- used to measure the patients muscle
strength in selected muscle bilaterally.

Appendix G
Short Form-36 Health Survey used to
assess the patients change in general
health and well-being as a result of the
exercise intervention

SF36 Health Survey

/f~,§m.~y~·~J~~.~~R.:;){:\;li~:set of questions ~sks for your views about your 'health. TJj}~ -!~t()rrf1.%ti8rt;.''·'> ~
.\Ntll help.:!<eep.·track of how you feel and howwell you are able to do your usiJai acttvttres ... Answer'
If you·are unsure about··t160to ~·~~w~:i.~:l'·• · T
'q1J~$'ti'Oo<t:>T€f~j3gd~IY:~Jh'e best answer. you can,
, , . ·
. , , ,
In general, would you say your health is: (Please tick one box.)

:;:~y~~~\}¥·g~)~\1;~~f;~~A~·~fbi'ng tne·answef'$sih<:Jicated.
1.

Excellent
Very Good
Good
Fair
Poor

~

_,

J
J
-]

J

Compared to one year ago, how would you rate your health in general now? (Please tick one box.)

2.

. :J

Much better than one year ago
Somewhat better now than one year ago
About the same as one year ago
Somewhat worse now than one year ago
Much worse now than one year ago

:J
:J .
:J
:J

a

The following questions are about activities you might do during typical day. Does your health
now limit you in these activities? If so, how much?
(Please circle one number on each line.)

3.

Yes,
Limited
A Lot

Activities
3(a)

Yes,
Limited A
Little

Not
Limited
At All

2

3

Vigorous activities, such as running, lifting. heavy objects,

.. P.~0.i.Y.i.P.~~.i.l).9. !.t:J..?.tr_e.lll1.0.L1 :3. spqrt? .........................................................................................................................
3(b)

Moderate activities, such as moving a table, pushing a

2

3

...Y.?. ~\J !:l.r:-0.. ~)~.?D~X ,..1?.9~!! ~9.,. (l.r. P..I.E.JYi.Cl9 ..99!!............................. ... ........ ... ... ...............................................................
...~.\H!!!9..9f..~~f.IY.!~9..9f.~~~.~i.~::? ...................................................................... ......... !..........

. 3( e)

...........?................... .3. ........ .
...~.1!!!1.~\r1.9..~~.Y.~r.~!. !.l.i.9.~~.~..9f..~.~?. ir.~~ .....................................................................~.....................?.................. ..3. ........ .
...~.1)!!1.~lr19..~.~~}1.i.9bt9L~.~?.!r.~...................................................................... ......... !.. ~ ....... ...........?................... ) ........ .

3( f)

...I?.!?Dg).t:J.9,.~.t:l.~~.l.i!:'.9 ,..<?X. :?.~C?.q P..i.t:l.9 ........................................................................!.............. ~.....?................... } ........ .

3(g)

...IJY.?.Er19.. ~.<?.r.e..t.h.~.n.. ~ ..~.H.e............. .... .....................

3(h l

...IJY.?.\~lr19..?.~Y.~r.~! ..I?.!C?.c::.~~...........................................................................................................?. ................... ~ ........ .

3(i)

...IJY.?.\~!r19.. 9!~.~}~!C?.S:~...................................................

3(c)

3( d)

. .....................................................?...........

........ }

..................................................... ~................... .3 ..... ..

3(j)

Bathing or dressing yourself

2

3

4.

During the past 4 weeks, have you had any cif the following problems with your work or other
regular daily activities as a result of your physical health?
(Please circle one number on each line.)
Yes
No

4(a)

.. q l1.~. 9.C?.'t.'.ll. ~n. t.~. ~. !3.~ C?.l1 .n.t ..0. f..t i "!...e.. Y.<?.l!.::? P..~ r1 t_ .9 t1 ..'t.'~ r.k. 9. r..o.t ~ _e.r. C3.c.~i_yi ti ~ ~...............

4(b)

.. f.':~~~.r:-0.P.!!:?0.~9..1.~.~?..~.~.?.f.l..Y9!:!..W..C?.l1J9..1.i.~~ ..................................................................................L ............... ?........ .
.. W..~r~..Hf'!.l.i.~~~,Ut1 ..t.~~ ..~!~.~ ..<?.(.~(l.~~-~r.~.t.l:~r..~~~.i.v.iJ.i.e.? .............................................................1. ................ J ....... .

4(c)

......... ~......... ......... ~

4(d)

Had difficulty performing the work or other activities (for example, it took
extra effort)

5.

During the past 4 weeks, have you had any of the following problems with your work or other
regular daily activities as a result of any emotional problems (e.g. feeling depressed or anxious)?
(Please circle one number on each line.)
Yes
No

5(a)

5(b)
5(c)

2

.. q!:I.~.9~.':Y.Il.~n.tb.~.~-~C?.l1.n.!..o.f..~!~.e..Y.(l.Y..~P..~r1~..9~ ..w..o.~~..o.r..c?.t~.~~--E.J.Y.\iyi.t!~~.........................1.................. ?........ .
.. f.':~~.<?.l:~P.!.i§b.~9..1.~.?.?..~b.~!.l..Y.c?.l1..W..f?.l1)9..\i.~~- ............:......·..............................................................)................... ~........ .
Didn't do work or other activities as carefully as usual

1

2

6.

During the past 4 weeks, to what extent has your physical health or emotional problems interfered
with your normal social activities with family, friends, neighbours, or groups? (Please tick one box.)
Not at all
:1
Slightly
:1
Moderately
:1
Quite a bit
:1
Extremely
:1

7.

How much physical pain have you had during the past 4 weeks? (Please tick one box.)
None
:1
Very mild
:1
Mild
:J
Moderate
J
Severu
J
Very Severe
J

8.

During_ the past 4 weeks, how much did pain interfere with your normal work (including both work
outside the home and housework)? (Please tick one box.)
Not at all
J
A little bit
J
Moderately
:J
Quite a bit
J
Extremely
:J

9.

These questions are about how you feel and how things have been with you during the past 4
weeks. Please give the one answer that is closest to the way you have be.en feeling for each item.
(Please circle one number on each line.)

9(a)
9(b)
9(c)

All of
the
Time

Most
of the
Time

A Good
Bit of
the Time

Some
of the
Time

.. P.i.Q.Y9.\-!J~?.~Lf.Y.!L9!..1.i.(~1................................................L ...........2....... ....

3 ........ ...... A.......

.. tl.?.\JE?..Y(J!:'.. Q~.<?.f! ..<?.Y!=:.ry.f1_!?.1Y9.l,l.:".P..~r.s.<?.r17. .............1. ...........2. .

3

Have you felt so down in the dumps that

1

2

A Little
of the
Time

None ·
of the
Time

..... 5 .............?. ..... ..

...... A............. ~ .............?. ...... .

3

4

5

6

.. f! 9.~ ~ lr-!.9. ~(J.YJ.?.. S:b.~ ~r. Y9.l,l.. ~ P..?. ... .. ..... .. .... .. ... .... ... .. . .. .... .. ....... .......... .. ... ... ..... ..... .. ... ..... ..... . ...... ... ... .. .. .. ............. .
.. tl.?. \J~..Y(J!:'J~.I~..~?.! !T.l. .?. r-!.9.. P. .~.?. ~~-~Y.!? ...........................!..............?. .. ... . .........3......... ...... A....... .. ..... ~....... .. .....?. ..... ..
9(e) .. Q[Q.Y9.Y..b.~~~..?..!(JJ..Qf..?.!!.~X9Y.?. ............................ .......!....... ...... .? .............. .3. .............. .4 .............. ~ ..............?. ...... .
9(f)
.. t1.?.\JE?..Y.()~J~Jt9.9:-:Ynh~.<?.\1~.9 ..~D9..9.!\-!~.?. ........ :...........L ......... ..?.. ..............3. ........ ...... A....... ....... ~ ..............?. ..... ..
9(g) ..Qi.~tY9.Y..f.?.~l.:-:Y9X!'! ..~~~-?. ......................................... ..... ..!....... .......?. .. :........... .3. ........ ...... A....... ....... ~ ............ ..tL.o' ..
9(h) .. tl.?. \J~..Y.Q~.. ~f?.?. r! ..~.. h~.P.P.Y .P. f?.I:?.Qfl.?....................... .......1..............?.. ..... .........3......... ...... A....... ....... ~-...... .. .....?. ..... ..
Did ou feel tired?
1
2
3
4
5
6

9(d)

10.

11 .

During the past 4 weeks, how much of the time has your physical health or emotional problems
interfered with your social activities (like visiting with friends, relatives etc.) (Please tick one box.)
All of the time
0
Most of the time
0
Some of the time
0
A little of the time
0
None of the time
0
How TRUE or FALSE is each of the following statements for you?
(Please circle one number on each line.)

11(a)

Definitely
True

I seem to get sick a little easier than

Mostly
True

Don't
Know

Mostly
False

Definitely
False

2

3

4

5

.5?~.l:t ~!..P. f?.Q.P.lf?...................................................·. ... .......... .... .. .... ... ....... .. ... ...... .. ... .... .... .. .... ... .. ... ... .... .... . .. .................. ..

11 (b l

..!.i?.r:TI.9.9.. h!?.?.!tDY..~:".9X!Y.!?.<?.9Y...I..tfl9.'!Y: ...................... J ....................2. ............... :3........ ........ A......... .. ........!?. ........ ..
.. !.!?.~.P.~_<;:t..rr!Y..~-~!?.1.\h. ~.9.. 9.~.~ .~9!.:"~ ............................ J .....·............... ) .. .. .... ....... :3................ A......... .. ........!?. ..........
1

Thank You!.

2

3

4

5

Appendix H
Exercise Training booklet each patient
was given, illustrating and describing
sample exercises

SAUNDERS'

Personal Exercise Program

EXERCISES
~~~XPRESS'"'

EXEROSE SOFIWARE

Chest and Anterior Shoulder (Right arm)
Hold on to a high object with the right hand, keeping the right arm straight. Turn
the feet to the left and roti;lte the body to the left feeling the stretch across the front
of the shoulder.
Hold for
sees.
Repeat _ _ times.

© PhysioTools Lid

Stand or sit.
Stretch one arm over to the opposite shoulder by pushing it at the elbow with your
other arm. Hold the stretching approx. 20 sees. - relax.
Repeat_ times.

© PhysioTools Lid

Calf Stretch (Soleus) (Right leg)
Begin in a half-lunge position with your front leg bent, hands supported on the wall.
Lower your body towards the wall, pressing your leading foot into dorsiflexion.
Hold for
sees.
Repeat __ times.

© PhysioTools Lid

Half Lunge (Rightleg)
Begin half kneeling, and tighten your abdominal muscles to stabilise your trunk.
Press your trailing leg forwards, forcing your right hip into extension.
Hold for
sees.
Repeat __ times.

© Ph JSioTools Lid

Built on Tools® 3.0
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Gluteal Stretch (Right leg)
Lie on the floor with left leg straight. Flex the right knee and pull it upwards and
across towards the opposite shoulder.
Hold for
sees.
Repeat __ times.

© PhysioTools Ltd

Hamstring Stretch (Active knee extension) (Right leg)
Lie on the floor, flex your hip to 90°. Grip your hands behind the knee and actively
straighten the knee using your quadriceps muscles.
Hold for
sees.
Repeat __ times.

© PhysioTools Ltd

Lying on your back or sitting.
,("\

\ \
I

:

P\

~

Bend and straighten your ankles briskly. If you keep your knees straight during the
exercise you will stretch your calf muscles.
Repeat_ times.

© PhysioTools Ltd

Sitting with your foot on the floor.
Alternately raise the inner. border of your foot (big toe) and then the outer border
(little toe).
Repeat_ times.

© Ph ysioTools Ltd

Support your elbow on a table with your wrist straight and your fingers pointing
towards the ceiling.
Make a fist (thumb over fingers). Straighten your fingers and bring them apart.
Repeat_ times.

© P;·ysioTools Lid

Built on Tools® 3.0

2/3

Support below the finger joint to be exercised.·
Bend the middle joint of the finger. Assist the movement with your other hand.
Hold
sees.
Repeat_ times.

©PhysicTools Ltd

Support the wrist of the hand to be exercised.
Hold
sees.
Bend your wrist and assist the movement with your other hand.
Then straighten your wrist and assist the movement with your other hand. Hold
sees.
Repeat_ times.

©Physic Tools Ltd

With your thumb touch each finger-tip.
Repeat_ times.

© PhysicTools Ltd

Built on Tools® 3.0
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AUNDERS'

Personal Exercise Program

~CISES
~~~XPRESST"

D:ERCISE SOFIWARE

Provided for : Liam Johnson

3 Months

Shoulder Flexion
Stand facing a wall with your arms straight and hands on the wall.
Do push-ups against the wall keeping your body in a straight line.
Repeat_ times.

© PhysioTools Ltd

Shoulder Extension
Stand with your back against the wall. Keep your upper arm close to the side and
elbow at a right angle.
Push the elbow back against the wall.
Repeat _times.

© PhysioTools Ltd

Elbow Flexion
Stand or sit with arms hanging down. Hold _
palms forward.

kg handweights and turn your

Bend alternate elbows briskly.
Repeat _

times.

© PhysioTools Ltd

Elbow Extension
Sit or stand holding a_ kg handweight.
Bring the arm to be exercised up with the elbow pointing to the ceiling. Support the
elbow with the other hand. Straighten the arm holding the weight.
Repeat'_·_times.

© Phy ;ioTools Ltd

Built on Tools® 3.0

1/2

Upper Trunk Flexion
Stand or sit.
Push shoulders forward, stretch the arms diagonally forwards and down keeping
your chin in. Hold stretching 20 sees.
Repeat _times.

PhysioTools Ltd

Upper Trunk Extension
Sit with your back straight and feet firmly on the floor.
Pull your shoulder blades together while turning your thumbs and hands outwards.
Repeat_ times.

© Physic Tools Ltd

Horizontal Shoulder Abduction

+

Stand sideways next to a wall. Lift your arm so that your shoulder and elbow are at
right angles.
Push your forearm against the wall. Hold approx. _sees .
. Repeat_ times.

©Physic Tools ltd

Built on Tools® 3.0
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SAUNDERS'

Personal Exercise Program

EXERCISES
~~~XPRESS"'

EXEROSE SOFTWARE

Hip Flexion
Sit on the floor with one leg straight and the other bent with your arms around it.

Try to straighten your bent leg while resisting any movement with your arms for 5
sees. - relax. Then pull the leg closer to your i;>ody. Hold approx. 20 sees.
Repeat_ times.

© PhysioTools Lid

Hip Extension
Stand straight holding on to a chair.
Bring your leg backwards keeping your knee straight. Do not lean forwards.
Repeat_ times.

© PhysioTools Ltd

Hip Abduction
Stand straight holding on to a support.

Lift your leg sideways and bring it back keeping your trunk straight throughout the
exercise.
Repeat_ times.

© PhysioTools Lid

Knee Extension
Sitting with your arms crossed or using your arms to raise yourself up.
Stand up and then sit down slowly on a chair, using your arms to decellerate your
movement. (This can be made easier and more difficult by changing the height of
the chair). Maintain straight back throughout
Repeat_ times.

© Ph;sioTools Lid
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Knee Flexion
Stand. Hold onto a support and bring one leg slightly backwards.
Bend your knee and lift your foot off the floor. Hold _sees.
Repeat _._ times.

PhysioTools Ltd

Calf Raises (Using block or step)
Place the ball of the foot on a small (5 em) block or step. Press the heel to the
floor, keeping your legs straight. Pull your hip forwards over the toes to feel the
stretch in the calf, then slowly raise up, then back down again.
Hold for
sees.
Repeat _ _ times.

© PhysioTools Ltd
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Appendix I
Diary template given to each patient
with a workbook to record training
information and subjective feelings
experienced by the patients' as
requested by the investigator

,._

•
•
•

•
•

•

Date
Time of day
Duration of exercise session (minutes)
Exercises Performed and Quantity
VAS Rating upon waking
Fatigue (F)
0
Muscle soreness (MS)
0
Breathlessness (B)
0
VAS Rating immediately post-e:-;ercise session
Fatigue (F)
0
0
Muscle soreness (MS)
0
Breathlessness (B)

'I'

J>

•

Visual Analogue Scale (1-10 rating system)

l=Notatall

I 0 =Very much so

•

Rating of Perceived Exertion (RPE) for the exercise session (Borg 0-10 scale
to be completed 30 minutes post-exercise session)
o 0 =Rest
o 1 =Very, very easy
o 2 =Easy
o 3 = Moderate
o 4 = Somewhat hard
o 5 =Hard
0
6 =0
7 =Very hard
8 =0
9=0
0
I 0 =Maximal

•

Falls
o
o
o

When?
Why?
Injuries sustained as a result of the fall?

• ·Any other comments (for example: other strenuous activity undertaken, other
health issues, general feeling ofweilbeing)

Appendix J
Photos of IBM.study participant
consented by patient to be shown in
investigators Thesis

An IBM patient from the Australian Neuromuscular Research Institute. The photo on the right
clearly shows the muscular atrophy that is prominent in IBM patients knee extensors. Upon
closer inspection of this photo, scars on the knee can also be seen, which is also a common
feature of IBM patients as a result of falls they . are pre-disposed to with the quadriceps
weakness they are afflicted by. The two photo's on the right show the decreased joint range of
motion these· patients have in their finger and wrist flexors and extensors. Particularly reduced
finger flexion, and particularly the two fingers shown and their distal joints more so than the
proximal joints.

Appendix K
Honours Study Budget and Timeline

Project Budget
1.
2.

Edith Cowan University vehicle hire to transport exercise bikes to patients homes
-$300
Transport fare for patients to attend the Centre for Neuromuscular and
Neurological Disorders for patient assessment- $300

Project Timeline

Complete Thesis

March

April

August

September November

AppendixL
Table 3. Mean changes in muscle
strength of total patient group

'

~.

Table.3. Total group (n=7) mean (±SE) muscle strength data pre and post exercise
intervention, where P(T<=t) one-tail was used for any healthy/trained muscles, and
P(T<=t) two-tail for any diseased/trained or untrained and healthy/untrained muscles.

Muscle

Mean

P-value

Pre

Post

* p< 0.05

150.18

138.27

0.122

Knee Extension

7.32

6.66

0.805

Wrist Extension

9.87

9.08

0.271

7.45

7.64

0.652

Elbow Extension

7.45

6.83

0.067

Elbow Flexion

10.92

11.05

0.402

Shoulder Abduction

12.35

17.2

* 0.000

Hip Flexion

11.48

15.59

* 0.008

Hip Abduction·

9.02

10.57

* 0.041

Knee Flexion

10.46

11.53

* 0.027

Diseased/Untrained
Grip Strength

Diseased/Trained

Healthy/Untrained
Shoulder External Rotation

Healthy/Trained

